Memento Vivereremember to live
Data fetched

Not medical advice. This page maps what exists: what is approved, what is being studied, and where. Whether a trial takes you is up to the trial team.

All diseases

Atopic dermatitis

Also called eczema, atopic eczema.

62approved drugsFDA label259trials recruiting184 open now55late stagePhase 3 and 449countrieswith a trial site2026-10newest papertrial or review

What it is

A common chronic pruritic inflammatory skin disease with a strong genetic component. Onset typically occurs during the first 2 years of life.

Eczema is a term for several different types of skin swelling. Eczema is also called dermatitis. Most types cause dry, itchy skin and rashes on the face, inside the elbows and behind the knees, and on the hands and feet. Scratching the skin can cause it to turn red, and to swell and itch even more.Eczema is not contagious. The cause of eczema is unknown. It is likely caused by both genetic and environmental factors. Eczema may get better or worse over time, but it is often a long-lasting disease. People who have it may also develop hay fever and asthma.The most common type of eczema is atopic dermatitis. It is most common in babies and children, but adults can have it too. Read more at MedlinePlus.

Source: Monarch Initiative, MONDO:0004980 and MedlinePlus, fetched 2026-11-10.

Causes

Gene associations arrive in a later milestone.

MedlinePlus has a plain-language page on causes and risk factors: Eczema.

Source: MedlinePlus, fetched 2026-11-10.

Approved treatments

62 drugs whose FDA (United States) label names this disease under indications. Approval elsewhere differs.

  • Abrocitinib (Cibinqo)Pfizer Laboratories Div Pfizer Incicated for the treatment of adults and pediatric patients 12 years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable. Limitations of Use CIBINQO is not re
  • Betamethasone Acetate And Betamethasone Sodium Phosphate (Celestone Soluspan)Sportpharm LLCrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic Diseases Bullous dermatitis herpeti
  • Betamethasone Sodium Phosphate And Betamethasone Acetate (Betaloan Suik)Advanced Rx Pharmacy of Tennessee, LLCrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic Diseases Bullous dermatitis herpeti
  • Betamethasone Sodium Phosphate And Betamethasone Acetate, Bupivacaine Hydrochloride, Povidine Iodine (Marbeta 25 Kit)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic Diseases Bullous dermatitis herpeti
  • Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol (Marbeta L Kit)Advanced Rx of Tennessee, LLCrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic Diseases Bullous dermatitis herpeti
  • Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine, Iodixanol, Povidine Iodine (Bl-C Kit)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic Diseases Bullous dermatitis herpeti
  • Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine, Povidine Iodine (Betalido Kit)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic Diseases Bullous dermatitis herpeti
  • Bupivacaine Hydrochloride, Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidine Iodine (Blt-25 Kit)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpet
  • Cortisone AcetateChartwell RX, LLCequate trials of conventional treatment in: Seasonal or perennial allergic rhinitis Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Drug hypersensitivity reactions 6. Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa, such as: Allergic
  • Crisaborole (Eucrisa)Pfizer Laboratories Div Pfizer IncEUCRISA is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older. EUCRISA is a phosphodiesterase 4 inhibitor indicated for topical treatment of mild to moderate atopic dermatitis in adult a
  • Depo-Medrol, Lidocaine, Isopropyl Alcohol (Multi-Specialty Kit)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic Diseases : Bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis
  • DesonideCintex Services, LLCDesonide Gel, 0.05% is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. Patients should be instructed to use Desonide Gel, 0.05% for the minimum amount of time as necessary to achieve the desired results because of
  • DexamethasoneAdvanced Rx Pharmacy of Tennessee, LLCol of severe or incapacitating a llergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Dermatologic Diseases: Bul l ous dermatitis herpetiformis, exfoliat
  • Dexamethasone 1.5 MgProficient Rx LProl of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Dermatologic Diseases: Bullous dermatitis herpetiformis, exfoliativ
  • Dexamethasone IntensolSportpharm LLCrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative
  • Dexamethasone Sodium PhosphateHikma Pharmaceuticals USA Inc.ng allergic conditions intractable to adequate trials of conventional treatment in: Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Seasonal or perennial allergic rhinitis Drug hypersensitivity reactions Urticarial transfusion reactions Acute noninfectious laryngeal edema (epinephrine is the drug o
  • Dexamethasone Sodium Phosphate, Bupivacaine Hydrochloride, Povidine Iodine (Mardex 25 Kit)Asclemed USA, Inc.ng allergic conditions intractable to adequate trials of conventional treatment in: Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Seasonal or perennial allergic rhinitis Drug hypersensitivity reactions Urticarial transfusion reactions Acute noninfectious laryngeal edema (epinephrine is the drug o
  • Dexamethasone Sodium Phosphate, Lidocaine Hydrochloride, Maricaine, Povidine Iodine (Dexlido-M Kit)Asclemed USA, Inc.ng allergic conditions intractable to adequate trials of conventional treatment in: Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Seasonal or perennial allergic rhinitis Drug hypersensitivity reactions Urticarial transfusion reactions Acute noninfectious laryngeal edema (epinephrine is the drug o
  • Dexamethasone Sodium Phosphate, Lidocaine Hydrochloride, Povidine Iodine (Dexlido Kit)Asclemed USA, Inc.ng allergic conditions intractable to adequate trials of conventional treatment in: Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Seasonal or perennial allergic rhinitis Drug hypersensitivity reactions Urticarial transfusion reactions Acute noninfectious laryngeal edema (epinephrine is the drug o
  • Dexamethasone Sodium Phosphate, Povidine Iodine (Doubledex Kit)Asclemed USA, Inc.ng allergic conditions intractable to adequate trials of conventional treatment in: Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Seasonal or perennial allergic rhinitis Drug hypersensitivity reactions Urticarial transfusion reactions Acute noninfectious laryngeal edema (epinephrine is the drug o
  • Dexamethasone Sodium Phosphate, Ropivacaine Hydrochloride, Povidine Iodine (Ropidex)Asclemed USA, Inc.ng allergic conditions intractable to adequate trials of conventional treatment in: Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Seasonal or perennial allergic rhinitis Drug hypersensitivity reactions Urticarial transfusion reactions Acute noninfectious laryngeal edema (epinephrine is the drug o
  • Difamilast (Adquey)Acrotech Biopharma Incis indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis. ADQUEY is a phosphodiesterase 4 inhibitor indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis. (1)
  • Doxepin HydrochlorideTeva Pharmaceuticals USA, Inc.hloride cream, 5% is indicated for the short-term (up to 8 days) management of moderate pruritus in adult patients with atopic dermatitis or lichen simplex chronicus (see DOSAGE AND ADMINISTRATION ).
  • Dupilumab (Dupixent)Sanofi-Aventis U.S. LLCDUPIXENT is an interleukin-4 receptor alpha antagonist indicated: Atopic Dermatitis for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or
  • Fluocinolone AcetonideSun Pharmaceutical Industries, Inc.Fluocinolone acetonide topical oil is a corticosteroid indicated for the topical treatment of atopic dermatitis in adult patients ( 1.1 ) topical treatment of moderate to severe atopic dermatitis in pediatric patients 3 months and older for up to 4 weeks ( 1.2 ) Limitations of Use: Apply the l
  • Fluticasone PropionatePadagis Israel Pharmaceuticals Ltdasone propionate lotion is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of atopic dermatitis in patients 3 months of age or older. Fluticasone propionate lotion is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of atopic dermatitis
  • HydrocortisoneSolco Healthcare LLCs of conventional treatment: Seasonal or perennial allergic rhinitis Serum sickness Bronchial asthma Contact dermatitis Atopic dermatitis Drug hypersensitivity reactions 6. Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic conjunctivitis
  • Hydrocortisone Acetate, IodoquinolKMM Pharmaceuticals, LLCuncil and subsequent FDA classification for that drug, the indications are as follows: “Possibly” Effective: Contact or atopic dermatitis; impetiginized eczema; nummular eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; loc
  • Hydrocortisone ButyrateThe J. Molner Company LLCHydrocortisone Butyrate Lotion is indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. Hydrocortisone Butyrate Lotion is a corticosteroid indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 mont
  • Hydrocortisone Sodium SuccinateZydus Pharmaceuticals USA Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosi
  • Kenalog (Pro-C-Dure 6 Kit)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpet
  • Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine (Physician Ez Use Joint Tunnel And Trigger Kit Ii)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpet
  • Lidocaine, Kenalog, Povidone Iodine (Lidolog Kit)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpet
  • Marcaine, Kenalog, Povidone Iodine (Bupivilog Kit)Advanced Rx of Tennessee, LLCrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpet
  • Marcaine, Lidocaine, Kenalog, Povidone Iodine (Mlk Kit F2)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpet
  • MethylprednisoloneBryant Ranch Prepacksonal or perennial allergic rhinitis Drug hypersensitivity reactions Serum sickness Contact dermatitis Bronchial asthma Atopic dermatitis 6. Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic corneal marginal ulcers Herpes zoster ophthalmi
  • Methylprednisolone AcetateA-S Medication Solutionsrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic Diseases: Bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis
  • Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol (Dyural 80-Lm)Advanced Rx Pharmacy of Tennessee, LLCrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic Diseases : Bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis
  • Methylprednisolone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Sodium Chloride, Isopropyl Alcohol (Dyural 40 Kit)Advanced Rx Pharmacy of Tennessee, LLCrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic Diseases : Bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis
  • Methylprednisolone Acetate, Lidocaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol (Dyural L Kit)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic Diseases : Bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis
  • Methylprednisolone Sodium SuccinateHikma Pharmaceuticals USA Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis
  • Niccolum Sulphuricum, Kali Bromatum, Kali Muriaticum, Hepar Sulphuris Calcareum, Kali Bichromicum, Kali Sulphuricum, Sulphur. (Eczema)PLYMOUTH HEALTHCARE PRODUCTS LLCUses: For the temporary relief of Eczema & Atopic Dermatitis symptoms.
  • PimecrolimusOceanside Pharmaceuticalseam, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatments, or when those treatments are no
  • Potassium Bromide, Nickel Sulfate, And Sulfur (Eczemol)PLYMOUTH HEALTHCARE PRODUCTS LLCINDICATIONS ECZEMOL ® is indicated for the treatment of moderate to severe eczema and atopic dermatitis. It has been found to work well with a variety of combination therapies.
  • Potassium Bromide, Nickel Sulfate, And Zinc Bromide (Psorizide Ultra)PLYMOUTH HEALTHCARE PRODUCTS LLCINDICATIONS PSORIZIDE ® ULTRA is indicated for the treatment of moderate to severe eczema, atopic dermatitis, seborrhea and seborrheic dermatitis. It has been found to work well with variety of combination therapies. Psoriasis also responds, but generally has a more favorable response to PS
  • PrednisoloneAurobindo Pharma Limiteds of conventional treatment: Seasonal or perennial allergic rhinitis Serum sickness Bronchial asthma Contact dermatitis Atopic dermatitis Drug hypersensitivity reactions 6. Ophthalmic diseases . Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic conjunctiviti
  • Prednisolone Oral (Prednisolone)Chartwell Governmental & Specialty RX, LLC.adequate trials of conventional treatment: Seasonal or perennial allergic rhinitis Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Drug hypersensitivity reactions 6. Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic
  • Prednisolone Oral Solution (Prednisolone)Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.adequate trials of conventional treatment: Seasonal or perennial allergic rhinitis Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Drug hypersensitivity reactions 6. Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic
  • Prednisolone Sodium PhosphateProficient Rx LPtreatment in adult and pediatric populations with: seasonal or perennial allergic rhinitis; asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions. 2. Dermatologic Diseases Pemphigus; bullous dermatitis herpetiformis; severe erythema multiforme (Stevens-Johnson syndrome); exfolia
  • PrednisoneA-S Medication Solutionsadequate trials of conventional treatment: Seasonal or perennial allergic rhinitis Bronchial asthma Contact dermatitis Atopic dermatitis Serum sickness Drug hypersensitivity reactions 6. Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: Allergic
  • Prednisone D/PDirect_Rxequate trials of conventional treatment: seasonal or perennial allergic rhinitis; bronchial asthma; contact dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity reactions. Ophthalmic Diseases Severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as: allergic
  • Ruxolitinib (Opzelura)Incyte Corporations kinase (JAK) inhibitor indicated for: the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies
  • Solu-CortefHF Acquisition Co. LLC, DBA HealthFirstrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases Bullous dermatitis herpeti
  • Solu-MedrolHF Acquisition Co. LLC, DBA HealthFirstrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases Bullous dermatitis herpeti
  • Solu-Medrol(R) Methylprednisolone Sodium SuccinatHF Acquisition Co LLC, DBA HealthFirstrol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases Bullous dermatitis herpeti
  • TacrolimusE. Fougera & Co. a division of Fougera Pharmaceuticals, LLCears, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not ad
  • Tacrolimus Ointment 0.1% (Tacrolimus)Encube Ethicals, Inc.ears, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not ad
  • Tapinarof (Vtama)Organon LLCn receptor agonist indicated for: the topical treatment of plaque psoriasis in adults. ( 1.1 ) the topical treatment of atopic dermatitis in adults and pediatric patients 2 years of age and older. ( 1.2 ) 1.1 Plaque Psoriasis VTAMA ® cream is indicated for the topical treatment of plaque psoriasis in adults. 1.2 Atopic
  • Tralokinumab-Ldrm (Adbry)LEO Pharma Inc.ADBRY is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and pediatric patients 12 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. A
  • Triamcinolone AcetonideAlembic Pharmaceuticals Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpet
  • Triamcinolone Acetonide, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine (Mlk F4 Kit)Asclemed USA, Inc.rol of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpet
  • Upadacitinib (Rinvoq)AbbVie Inc.icated for the treatment of adults and pediatric patients 12 years of age and older with refractory, moderate to severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies are inadvisable. ( 1.3 ) Limitations of Use RINVOQ i

Source: openFDA drug labels, fetched 2026-11-10.

Latest research

The newest randomized trials, meta-analyses and systematic reviews with this disease in the title. 1733 in total.

  1. Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitisJ Dermatolog Treat ·
  2. Outcomes and Predictors of Sustained Response After Dose Tapering of Targeted Therapies in Moderate-to-Severe Atopic Dermatitis: A Systematic ReviewAm J Clin Dermatol ·
  3. The Potential Role of Mesenchymal Stem Cell Therapy for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Human Clinical TrialsStem Cells Dev ·
  4. Effect of Abrocitinib on the Skin Microbiome in Patients With Moderate-to-Severe Atopic DermatitisAllergy · · open access
  5. Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trialsJ Dermatolog Treat ·
  6. Early response to ivarmacitinib and its impact on long-term efficacy in patients with moderate-to-severe atopic dermatitis: a <i>post hoc</i> analysis of a phase-III trialJ Dermatolog Treat ·
  7. Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyJ Am Acad Dermatol ·
  8. Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trialJ Dermatolog Treat ·
  9. Comparative Efficacy and Safety of Adjunctive 0.015% Triamcinolone Acetonide Topical Spray With Lokivetmab Versus Lokivetmab Monotherapy as 'Reactive Therapy' for Canine Atopic Dermatitis: A Randomised, Single-Blinded, Controlled Preliminary TrialVet Dermatol ·
  10. Faecal Microbiota Transplantation Reduces Lesion Severity and Medication Use in Canine Atopic Dermatitis: A Randomised, Placebo-Controlled, Double-Blinded Clinical TrialVet Dermatol · · open access
  11. S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double-blind randomized clinical trial in patients with mild to moderate atopic dermatitisBr J Clin Pharmacol · · open access
  12. Efficacy of Oral Baicalin in Canine Atopic Dermatitis: A Randomised Placebo Controlled TrialVet Dermatol ·
  13. Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitisJ Dermatolog Treat ·
  14. Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis: a network meta-analysis of phase 3-4 randomized trialsJ Dermatolog Treat ·
  15. Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitisJ Dermatolog Treat ·
  16. Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 yearsJ Dermatolog Treat ·
  17. Ivarmacitinib in patients with moderate to severe atopic dermatitis stratified by baseline characteristics: a post-hoc analysis of a phase 3 clinical trialJ Dermatolog Treat ·
  18. Atopic dermatitis and the risk of osteoporosis and fractures: a meta-analysis of cohort studiesAnn Med · · open access
  19. Nemolizumab for chronic pruritus beyond atopic dermatitis and prurigo nodularis: a systematic review and synthesis of emerging evidenceJ Dermatolog Treat ·
  20. Use of Extended Dosing Intervals of Dupilumab in Treatment of Atopic Dermatitis: A Systematic Review and Meta-AnalysisDermatitis ·

Source: Europe PMC, fetched 2026-11-10.

Trials recruiting now

259 studies on ClinicalTrials.gov are recruiting (184) or about to (75). Most advanced first. Phase 3 is the last step before approval; Phase 1 is the first time in people.

Phase 4 18 Phase 3 37 Phase 2/3 4 Phase 2 39 Phase 1/2 4 Phase 1 29 No phase given 52 Observational 76

Loading all 259 trials for filtering…

Phase 4, after approval 18
  1. The Impact of Dietary Salt on the Severity of EczemaNCT07447063 · Recruiting · started · Sodium chloride tablets; Placebo TabletsUnited States (2)
  2. Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.NCT07560618 · Recruiting · started · Roflumilast Cream 0.15%United States
  3. The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin DiseaseNCT07487831 · Recruiting · started · Sodium chloride tablets; Placebo TabletsUnited States (2)
  4. Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic DermatitisNCT05042258 · Recruiting · started · DupilumabUnited States
  5. Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in ChildrenNCT05758532 · Recruiting · started · Measles-Mumps-Rubella vaccine (MMR)Switzerland
  6. Molecular Signatures of Cutaneous Dupilumab ResponseNCT05858619 · Recruiting · started · DupilumabUnited States
  7. Ethnic Differences in Mechanisms of Action of DupilumabNCT05268107 · Recruiting · started · DupilumabUnited States
  8. Dupixent and Narrowband UVB for Atopic DermatitisNCT05285839 · Recruiting · started · DupixentUnited States
  9. Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis PatientsNCT06397781 · Not yet recruiting · started · Skin Cleanser Combination No.1United States
  10. Opzelura Experience StudyNCT07661979 · Not yet recruiting · started · ruxolitinib; ruxolitinib and an Eczema Action PlanUnited States
  11. AD Treatment Optimization With Ebglyss in Real-World Practice: A Multicenter Study of Patient-Centered OutcomesNCT07856134 · Not yet recruiting · started · Lebrikizumab-lbkzUnited States (10)
  12. A Study to Investigate Dupixent/ Dupilumab in Adult Indian Participants With Moderate-to-severe Atopic DermatitisNCT07905547 · Not yet recruiting · started · DupilumabNo sites listed yet
  13. Abrocitinib Dose Tapering in Patients With Atopic DermatitisNCT07848074 · Not yet recruiting · started · AbrocitinibNo sites listed yet
  14. Azithromycin in Atopic DermatitisNCT07713186 · Not yet recruiting · started · Betamethasone or tacrolimus ointments; AzithromycinEgypt
  15. Utilization of a Microdevice for Psoriasis and Atopic DermatitisNCT07352566 · Not yet recruiting · started · In situ cutaneous microdevice; Triamcinolone; 5-Fluorouracil; CalcipotrieneUnited States
  16. Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic DermatitisNCT07437534 · Not yet recruiting · started · Crisaborole 2% Topical Application Ointment [EUCRISA; tacrolimus 0.1%Pakistan
  17. Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic EczemaNCT07438509 · Not yet recruiting · started · Placebo Cream; Crisaborole 2% CreamNo sites listed yet
  18. Comparative Study of Crisaborole vs. Tacrolimus in Atopic DermatitisNCT07367932 · Not yet recruiting · started · Application of crisaborole twice daily; Tacrolimus ointment in atopic dermatitisNo sites listed yet
Phase 3 37
  1. Roflumilast Cream 0.3% for Moderate to Severe Atopic DermatitisNCT07916480 · Recruiting · started · Roflumilast Cream 0.3%; Vehicle CreamUnited States (4)
  2. Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisNCT07762833 · Recruiting · started · Nemolizumab 30 mg; PlaceboChina
  3. Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)NCT07767253 · Recruiting · started · 611; 611; Matching placeboChina (5)
  4. A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic DermatitisNCT07754786 · Recruiting · started · Dupilumab Injection; IBI3027China
  5. A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaNCT07783425 · Recruiting · started · Tilrekimig; Dupilumab; Placebo for Tilrekimig; Placebo for DupilumabUnited States (34), Japan (14), Canada, Taiwan
  6. A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaNCT07765888 · Recruiting · started · Tilrekimig; PlaceboUnited States (14), Japan (7)
  7. A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic DermatitisNCT07711418 · Recruiting · started · Rezpegaldesleukin; PlaceboUnited States (13)
  8. A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic DermatitisNCT07690371 · Recruiting · started · Rezpegaldesleukin; PlaceboUnited States (20)
  9. Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic DermatitisNCT07592585 · Recruiting · started · VC005; VC005 PlaceboChina
  10. A Study of Lebrikizumab in Adults With Nummular EczemaNCT07542483 · Recruiting · started · Lebrikizumab; PlaceboGermany
  11. A Study of SHR-1819 Injection in Adolescents With Severe Atopic DermatitisNCT07309055 · Recruiting · started · SHR-1819 Injection; SHR-1819 Injection PlaceboChina (2)
  12. Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic DermatitisNCT07370909 · Recruiting · started · LW402; PlaceboChina
  13. A Phase III Study of GS101 Injection to Dupixent®NCT07386743 · Recruiting · started · GS101 injection; DUPIXENT®China
  14. A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe EczemaNCT06807281 · Recruiting · started · AbrocitinibUnited States (11), China (7), Poland (6), Japan (5) and 3 more
  15. Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic DermatitisNCT07042126 · Recruiting · started · 611; Matching placeboChina (3)
  16. A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe EczemaNCT06807268 · Recruiting · started · Abrocitinib; PlaceboUnited States (13), China (8), Poland (7), Hungary (5) and 4 more
  17. Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic DermatitisNCT06880276 · Recruiting · started · 1.5% QLM3003 ointment; 2% QLM3003 ointment; QLM3003 PlaceboChina
  18. Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic DermatitisNCT06723080 · Recruiting · started · VC005 low dose group; VC005 high dose group; VC005 Placebo groupChina
  19. VItamin D in pregnanCy for prevenTion Of eaRlY Childhood AsthmaNCT06570889 · Recruiting · started · Cholecalciferol D3; Olive oilDenmark
  20. Fish Oil in pREgnancY for Personalized Prevention of Early Childhood AsthmaNCT06560255 · Recruiting · started · n-3 fatty acid; Rape seed oilDenmark
  21. ICP-332 in Subjects With Moderate to Severe Atopic DermatitisNCT06775860 · Recruiting · started · ICP-332 Tablets; ICP-332 Placebo TabletsChina (62)
  22. A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic DermatitisNCT06311682 · Recruiting · started · Tralokinumab + TCS; Placebo + TCSUnited States (15), Canada (10), South Korea (9), Poland (8) and 9 more
  23. A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic DermatitisNCT06587685 · Recruiting · started · PG-011Gel; VehicleChina
  24. Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.NCT06239311 · Recruiting · started · Methotrexate; PlaceboPoland (12), Czechia (8), Italy (6), France (4)
  25. Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of AgeNCT07823595 · Not yet recruiting · started · Abrocitinib; PlaceboNo sites listed yet
  26. Pharmacokinetics, Immunogenicity and Safety of Subcutaneous Dupilumab and Berahyaluronidase Alfa (ALT-B4) CoformulationNCT07919899 · Not yet recruiting · started · Dupilumab coformulated with berahyaluronidase alfa; DupilumabNo sites listed yet
  27. A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic DermatitisNCT07873801 · Not yet recruiting · started · Lebrikizumab; Placebo; Lebrikizumab; LebrikizumabNo sites listed yet
  28. Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic DermatitisNCT07377838 · Not yet recruiting · started · ADSTEM Inj.; PlaceboNo sites listed yet
  29. Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic DermatitisNCT07162896 · Not yet recruiting · started · Crisaborole 2%; Tacrolimus 0.1%Pakistan
  30. A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic DermatitisNCT07479615 · Not yet recruiting · started · MG-K10 Humanized Monoclonal Antibody InjectionNo sites listed yet
  31. A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic DermatitisNCT07540442 · Not yet recruiting · started · MG-K10 Injection (Humanized Monoclonal Antibody); Placebo for MG-K10China
  32. A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic DermatitisNCT07173478 · Not yet recruiting · started · OPA-15406; VehicleJapan
  33. A Study of Stapokibatrt in Children Subjects With Atopic DermatitisNCT07106372 · Not yet recruiting · started · StapokibatrtChina
  34. A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic DermatitisNCT07184645 · Not yet recruiting · started · OPA-15406; VehicleJapan
  35. Study of Stapokibatrt in Children Subjects With Atopic DermatitisNCT06956196 · Not yet recruiting · started · Stapokibatrt; PlaceboChina
  36. A Phase Ⅲ Comparative Study of QL2108 to Dupixent®NCT06884891 · Not yet recruiting · started · QL2108 injection; Dupixent®No sites listed yet
  37. A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic DermatitisNCT06767540 · Not yet recruiting · started · Placebo; placeboChina (28)
Phase 2/3 4
  1. A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)NCT07355075 · Recruiting · started · GX-03; VehicleUnited States
  2. Herbal Ointment in Treating Atopic Dermatitis TopicallyNCT06850311 · Recruiting · started · herbal ointment; PlaceboTaiwan
  3. Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis ChildrenNCT04419584 · Recruiting · started · Modified Qing-Ying Decoction; Identical looking placeboHong Kong
  4. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic DermatitisNCT07784816 · Not yet recruiting · started · TLL-018 tablets; TLL-018 tablets; TLL-018 tablets; PlaceboChina
Phase 2 39
  1. A Study for AR100DP1 in Mild to Moderate Atopic DermatitisNCT07914088 · Recruiting · started · 0.5% AR100DP1; PlaceboTaiwan (2)
  2. Phase II Clinical Study to Evaluate the Efficacy and Safety of LT-002-158 Tablets in Adult Patients With Moderate-to-Severe Atopic DermatitisNCT07895615 · Recruiting · started · LT-002-158; PlaceboChina
  3. PRA-216 Atopic Dermatitis Safety and Efficacy StudyNCT07810777 · Recruiting · started · Active PRA-216; PlaceboAustralia (5), New Zealand (4)
  4. A Study Evaluating TRIV-573 in Atopic DermatitisNCT07782333 · Recruiting · started · TRIV-573; PlaceboUnited States (13), Canada (2), Ukraine (2)
  5. Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic DermatitisNCT07660835 · Recruiting · started · NemolizumabUnited States
  6. A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisNCT07643766 · Recruiting · started · ENV-294; PlaceboUnited States (9)
  7. A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic DermatitisNCT07598383 · Recruiting · started · VC005 group; VC005 Placebo groupChina
  8. A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisNCT07599813 · Recruiting · started · Camoteskimab; PlaceboUnited States (33), Poland (14), Canada (9), Germany (7) and 4 more
  9. A Clinical Study to Evaluate SM17 for Atopic DermatitisNCT07445919 · Recruiting · started · SM17 for subcutaneous injection; SM17 placebo for subcutaneous injectionChina
  10. A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic DermatitisNCT07399067 · Recruiting · started · IBI3002; Placebo; DupilumabChina
  11. A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic DermatitisNCT07193589 · Recruiting · started · The high-dose group of ZL-82 tablets; The low-dose group of ZL-82 tablets; The placebo groupChina
  12. Study to Evaluate Soquelitinib in Participants With Moderate to Severe ADNCT07441395 · Recruiting · started · Soquelitinib; PlaceboUnited States
  13. Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down SyndromeNCT07242638 · Recruiting · started · AbrocitinibUnited States
  14. Study of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisNCT07298395 · Recruiting · started · ENV-294; PlaceboUnited States (32)
  15. A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.NCT07230483 · Recruiting · started · CM512China
  16. A Study to Learn About Study Medicine Called PF-08049820 in People With EczemaNCT07216027 · Recruiting · started · PF-08049820; PlaceboUnited States (18), Poland (7), Japan (6), China (5) and 5 more
  17. Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot StudyNCT07297602 · Recruiting · started · Oral roflumilastEgypt
  18. A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic DermatitisNCT07211542 · Recruiting · started · SHR-1905 Injection; SHR-1905 Injection Blank PreparationChina
  19. A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult PatientsNCT07073677 · Recruiting · started · IN-115314 Ointment 1%; IN-115314 Ointment 3%; IN-115314 Ointment placeboSouth Korea
  20. Study of CM512 in Patients With Moderate-to-Severe Atopic DermatitisNCT06947980 · Recruiting · started · Placebo Comparator; CM512China
  21. A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic DermatitisNCT07037901 · Recruiting · started · IMG-007; PlaceboUnited States (16), Canada (7), Australia (5), New Zealand (2)
  22. Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic DermatitisNCT06947993 · Recruiting · started · GHZ339; PlaceboUnited States (24), Germany (9), China (8), Japan (8) and 13 more
  23. A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisNCT07003425 · Recruiting · started · APG777; APG777; APG777United States (23), Canada (15), Germany (14), Poland (11) and 5 more
  24. Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.NCT06855745 · Recruiting · started · zabalafinAustralia (12)
  25. Cardamom and Topical Roseomonas in Atopic DermatitisNCT06096857 · Recruiting · started · Roseomonas mucosa (RSM2015) and Cardamom seeds; Placebo (sucrose)United States
  26. A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of LutikizumabNCT06524635 · Recruiting · started · LutikizumabUnited States (2)
  27. Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic DermatitisNCT06397911 · Recruiting · started · FB825; PlaceboTaiwan (10), United States (6)
  28. Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic DermatitisNCT03835767 · Recruiting · started · Peanut powder and Oat flour; Peanut flour and Oat flour (placebo for peanut flour); Dry Milk Powder and Corn Starch (placebo for Milk powder); Baked milk and Rice milk (placebo for Baked milk)United States
  29. Effects of Treatments on Atopic DermatitisNCT01631617 · Recruiting · started · Trimethoprim/sulfamethoxazole (TMP/SMZ); Cephalexin; Doxycycline; Sodium hypochloriteUnited States
  30. Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic DermatitisNCT06487000 · Not yet recruiting · started · EC-18; Placebo EC-18No sites listed yet
  31. To Evaluate the Safety and Efficacy of Hemay5394 in Patients With Mild to Moderate Atopic DermatitisNCT07877155 · Not yet recruiting · started · Hemay5394 group; Control groupAustralia
  32. A Study of JYP0066 Cream in Mild-to-Moderate Atopic DermatitisNCT07843290 · Not yet recruiting · started · JYP0066 4% topical cream; 3% JYP0066 topical cream; 2% JYP0066 topical cream; Matching placebo cream (vehicle, no active ingredient)No sites listed yet
  33. The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe ItchingNCT07678645 · Not yet recruiting · started · Upadacitinib 15 MGChina
  34. A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic DermatitisNCT07502222 · Not yet recruiting · started · AK139 and placebo; AK139; AK139 and placebo; AK139No sites listed yet
  35. A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic DermatitisNCT07344051 · Not yet recruiting · started · QLS12010; PlaceboNo sites listed yet
  36. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic DermatitisNCT07465120 · Not yet recruiting · started · CMS-D001 50mg; CMS-D001 100mg; CMS-D001 200mg; PlaceboChina (28)
  37. A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic DermatitisNCT07175233 · Not yet recruiting · started · SIM0278 injection; PlaceboChina (2)
  38. Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic DermatitisNCT07054736 · Not yet recruiting · started · XKH001 Injection; XKH001 Placebo InjectionChina
  39. A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)NCT06756126 · Not yet recruiting · started · AK120China (6)
Phase 1/2 4
  1. HL-300 Ointment in Patients With Mild-to-Moderate Atopic DermatitisNCT07629778 · Recruiting · started · HL-300; Placebo; HL-300; HL-300China
  2. A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic DermatitisNCT06931990 · Recruiting · started · LT-002-158 tabletsChina
  3. IB/IIa Study of MG-K10 in Adolescent Moderately Severe PatientsNCT06765005 · Recruiting · started · MG-K10China
  4. Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic DermatitisNCT07782476 · Not yet recruiting · started · HXN6005; Placebo; HXN6005; PlaceboChina
Phase 1 29
  1. Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic DermatitisNCT07262983 · Recruiting · started · baricitinibUnited States
  2. Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic DermatitisNCT07800104 · Recruiting · started · QX4533; QX4533 PlaceboChina
  3. A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic DermatitisNCT07746817 · Recruiting · started · BYN-001; PlaceboAustralia
  4. A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic DermatitisNCT07604324 · Recruiting · started · DCY636; PlaceboJapan
  5. Study of S-4321 in Participants With an Autoimmune or Immune-mediated DiseaseNCT07455578 · Recruiting · started · S-4321Australia (2)
  6. First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic DermatitisNCT07527923 · Recruiting · started · REGN20423; PlaceboUnited States (8), Belgium
  7. A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic DermatitisNCT07693738 · Recruiting · started · SSGJ-716; PlaceboChina
  8. A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis ParticipantsNCT07488065 · Recruiting · started · SKB575 Injection/SKB575 PlaceboChina (2)
  9. Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234NCT07453602 · Recruiting · started · ARQ-234; PlaceboUnited States (7)
  10. A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.NCT07358156 · Recruiting · started · CKD-706; US-Dupixent; EU-DupixentGermany, United Kingdom
  11. A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic DermatitisNCT07235384 · Recruiting · started · ZL-1503; Placebo; ZL-1503; PlaceboChina (6), New Zealand (6), Australia (2)
  12. A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)NCT07239947 · Recruiting · started · BBT001; PlaceboChina (10)
  13. A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic DermatitisNCT07015762 · Recruiting · started · IBI3002; PlaceboChina
  14. Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and PsoriasisNCT06982352 · Recruiting · started · LPX-TI641; PlaceboUnited States (2), Jordan
  15. Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)NCT06504160 · Recruiting · started · ShA9 Topical Gel; Hydrocortisone Ointment; Clobetasol Ointment; Fluocinonide OintmentUnited States (8)
  16. Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic DermatitisNCT06934252 · Recruiting · started · TRB-061; TRB-061; TRB-061; PlaceboNew Zealand (10), Australia (9)
  17. A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis PatientsNCT06946641 · Recruiting · started · QLS12010; PlaceboChina
  18. A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)NCT06808477 · Recruiting · started · BBT001; PlaceboNew Zealand (5), Poland (4), United States (3), Australia (2)
  19. A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic DermatitisNCT07558668 · Recruiting · started · SYX-5219 Oral CapsuleUnited States (6), Germany (3), United Kingdom (2), Bulgaria and 2 more
  20. FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsNCT06564389 · Recruiting · started · PF-07832837; PlaceboUnited States (5), Poland (3)
  21. A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic DermatitisNCT06055361 · Recruiting · started · BxC-I17e (primed iMSC derived Extracellular vesicles(EV)); PlaceboUnited States (3)
  22. A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult ParticipantsNCT07920783 · Not yet recruiting · started · GLR2053 Tablets; PlaceboChina
  23. A Study of NOR-101 in Healthy Adults and Adults With Moderate-to-Severe Atopic DermatitisNCT07904689 · Not yet recruiting · started · NOR-101; PlaceboAustralia
  24. A Study of HSK60002 Tablets in Participants With Moderate-to-Severe Atopic DermatitisNCT07920809 · Not yet recruiting · started · HSK60002 tablets; HSK60002 PlaceboNo sites listed yet
  25. A Phase I Study of HXN5003 in Healthy Participants and Patients With Moderate-to-Severe Atopic DermatitisNCT07801612 · Not yet recruiting · started · HXN5003; Placebo; HXN5003; PlaceboChina
  26. A Clinical Study of HRS-8797 in Healthy ParticipantsNCT07698756 · Not yet recruiting · started · HRS-8797; PlaceboChina
  27. A Dose Escalation Phase 1 Study of HXN5003 in Healthy ParticipantsNCT07549750 · Not yet recruiting · started · HXN5003; PlaceboAustralia
  28. A Study of IBI3033 in Moderate-to-Severe Atopic DermatitisNCT07549984 · Not yet recruiting · started · IBI3033; PlaceboChina
  29. A Study of Two Different Formulations of 611 in Healthy Adult Subjects in ChinaNCT07042113 · Not yet recruiting · started · new formulations of 611; existing formulations of 611China (2)
No phase given 52
  1. Digital Mindfulness Meditation in Adolescents With Atopic DermatitisNCT07746427 · Recruiting · started · Digital App Mindfulness Meditation; Mindfulness Meditation SheetUnited States (2)
  2. Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic DermatitisNCT07333378 · Recruiting · started · Retention of Vernix Caseosa After Birth; Removal of Vernix Caseosa After BirthChile (2)
  3. Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and AdultsNCT07358000 · Recruiting · started · Baume Relipid+France
  4. Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic DermatitisNCT07754968 · Recruiting · started · Bifidobacterium bifidum BFP19® and BFP29® (Bifipral®); PlaceboItaly
  5. Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept TrialNCT07341087 · Recruiting · started · Lactobacillus casei Shirota (LcS) Probiotic Drink; Skimmed Milk Control DrinkUnited Kingdom
  6. Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus CompleteNCT07444008 · Recruiting · started · BioAmicus Complete; PlaceboRussia
  7. Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology PatientsNCT06702293 · Recruiting · started · Digital psychotherapeutic intervention; Healthy365Singapore
  8. Flourish: Exploring the Early Infant Gut MicrobiomeNCT07333482 · Recruiting · started · Tailored Recommendations; Consult Call; Educational Email SeriesUnited States
  9. Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns.NCT07347743 · Recruiting · started · Two probiotic Limosilactobacillus reuteri strains; PlaceboBelgium
  10. Nigella Sativa Oil for Eczematous Otitis ExternaNCT07525505 · Recruiting · started · Mometasone Furoate (MF); Nigella sativa oilTurkey (Türkiye)
  11. PALLAS Laser for Skin DiseasesNCT07250997 · Recruiting · started · UVB laser treatmentHungary
  12. Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 WeeksNCT07014007 · Recruiting · started · RV4421B- EV0407Mauritius
  13. Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric PopulationNCT07259343 · Recruiting · started · glycomacropeptide; emollient creamMexico
  14. Novel Skin Barrier Product Versus Petrolatum for Skin Barrier DysfunctionNCT07183423 · Recruiting · started · Novel barrier repair topical product; PetrolatumPhilippines
  15. Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical ParametersNCT07056569 · Recruiting · started · 047_TD Dermatitis cream twice a day for 28 daysItaly (3)
  16. A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic DermatitisNCT07022288 · Recruiting · started · LA ROCHE-POSAY CICAPLAST BALM, Standard creamChina
  17. Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier FunctionNCT06943469 · Recruiting · started · Test formula; Control formulaSpain (9), France (6), Germany (5), Belgium (3) and 1 more
  18. CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic DermatitisNCT07204561 · Recruiting · started · CeraVe Moisturizing Cream; GalenicoItaly
  19. Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic DermatitisNCT06636240 · Recruiting · started · Mulberry fruit juice; Mometasone furoate 0.1% creamTaiwan (2)
  20. Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic DiseasesNCT06529913 · Recruiting · started · Collection of environmental, biological, and clinical dataItaly (2)
  21. Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell ProteomicsNCT06884163 · Recruiting · started · comprhensive spatial transcriptomic profile on lesional skin biopsiesItaly
  22. Role of Interleukin-13 Pathways on Pain and Itch SensitivityNCT06503510 · Recruiting · started · Histamine; Cowhage; bovine adrenal medulla (BAM8-22)Denmark (3)
  23. A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic EczemaNCT06453512 · Recruiting · started · Doublebase OnceUnited Kingdom
  24. Topical Treatment for Atopic DermatitisNCT06244212 · Recruiting · started · Demonstration of applying triamcinolone cream; Mobile App Use; Standard of CareUnited States
  25. AI App for Management of Atopic DermatitisNCT06362629 · Recruiting · started · Artificial Intelligence assistant decision-making system (AIADMS) AppChina
  26. Virtual Reality for Pain Management During Dupilumab InjectionNCT06182436 · Recruiting · started · Virtual Reality Distraction; Standard TreatmentCanada (2)
  27. Nationwide Research on the Rewilding of Kindergarten YardsNCT06390878 · Recruiting · started · Biodiversity; Playground equipmentFinland (2)
  28. Dietary Intervention on AtopyNCT06547372 · Recruiting · started · Dietary Intervention on AtopySingapore
  29. Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics ProjectNCT06300697 · Recruiting · started · Data and biospecimen collection; Skin biopsies; Oral Food Challenge (OFC) proceduresUnited States
  30. Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic DermatitisNCT07316465 · Recruiting · started · Development of atopic dermatitis with/without IgE autoantibodiesBelgium
  31. Sand Play - the Effect of Biodiversity Exposure on Atopic DermatitisNCT06390696 · Recruiting · started · Microbial intervention; PlaceboFinland (2)
  32. Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.NCT05575882 · Recruiting · started · Skin hydration; Barrier function measurement; Potential of hydrogen measurement (pH); Clinical evaluation of atopic dermatitisArgentina, India, Singapore
  33. Deployment o the Multidisciplinary Prospective Cohort ImminentNCT04334031 · Recruiting · started · Biobanking with genetic analysis; SF-12 questionnaireFrance
  34. Restoration of Microbiota in NeonatesNCT03928431 · Recruiting · started · Maternal microbiotaSweden
  35. Localized Aeroallergen Exposure in Atopic DermatitisNCT07918586 · Not yet recruiting · started · Localized grass pollen allergen exposure; Localized placebo exposureGermany (2)
  36. Cosmetic Efficacy Evaluation of Hydraporin AI Cream in Individuals With Atopic Dermatitis and PsoriasisNCT07918560 · Not yet recruiting · started · Investigational creamBrazil
  37. Efficacy and Tolerability of a Probiotic OintmentNCT07701447 · Not yet recruiting · started · Probiotic Ointment; Comparator productNo sites listed yet
  38. Oral Melatonin as Adjunctive Therapy in Adults With Atopic DermatitisNCT07842900 · Not yet recruiting · started · Melatonin; Standard Treatment for Atopic DermatitisNo sites listed yet
  39. Efficacy and Safety of Cream Containing Fig Extract in Subacute and Chronic Eczematous Dermatitis VolunteersNCT07867249 · Not yet recruiting · started · Fig extract cream; Placebo creamNo sites listed yet
  40. A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in DermatologyNCT07481019 · Not yet recruiting · started · Flexible ePROM-guided Scheduling System; electronic patient reported outcome measures (ePROMs)No sites listed yet

Showing the 40 most recent of 52. See every one on ClinicalTrials.gov.

Observational, no treatment given 76
  1. Observational Analytical Validation Study of the Replior ScratchSenseNCT07909967 · Recruiting · started · Scratch and sleep research trackingFrance
  2. PPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness RegistryNCT07598058 · Recruiting · started · Observational (Non-Interventional) RegistryUnited States
  3. Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under NemolizumabNCT07730788 · Recruiting · started France
  4. Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis FlaresNCT07645820 · Recruiting · started · Nevisense electrical impedance spectroscopyUnited States (16)
  5. A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)NCT07544862 · Recruiting · started · StapokibartChina
  6. Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.NCT06899204 · Recruiting · started · AbrocitinibUnited States
  7. Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in BabiesNCT07228962 · Recruiting · started United Kingdom
  8. The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic DermatitisNCT07467564 · Recruiting · started · DupilumabUnited Arab Emirates (4), Saudi Arabia (2), Qatar
  9. Study of Alloknesia in Atopic DermatitisNCT06923202 · Recruiting · started France (8)
  10. Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic DermatitisNCT07573735 · Recruiting · started · blood samplingChina
  11. This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic TreatmentNCT07290803 · Recruiting · started United States (46), China (11), France (7), Italy (4) and 5 more
  12. Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin DiseasesNCT06599411 · Recruiting · started · Sampling; SamplingFrance
  13. Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital ImpactNCT07444801 · Recruiting · started · tralokinumabGermany (2)
  14. Microbiome and Atopy in MaliNCT07051902 · Recruiting · started Mali (2)
  15. SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)NCT07021495 · Recruiting · started Netherlands (8)
  16. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & AdultsNCT06988605 · Recruiting · started United States (59), Germany (25), United Kingdom (24)
  17. Changes in Skin Myco- and Microbiome After Lebrikizumab TreatmentNCT07807228 · Recruiting · started Denmark
  18. Sodium in the Skin and Atopic DermatitisNCT06998446 · Recruiting · started United States (2)
  19. The Skin Barrier in Users of Diabetes DevicesNCT06856954 · Recruiting · started Sweden
  20. Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and PsoriasisNCT06801821 · Recruiting · started Italy
  21. A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-UpNCT06732414 · Recruiting · started United States
  22. A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic DermatitisNCT06815380 · Recruiting · started · No InterventionDenmark
  23. Global Healthcare Study on Atopic DermatitisNCT07659756 · Recruiting · started Switzerland
  24. Characterisation of Skin Microstructure Under Normal and Atrophied StatesNCT06954272 · Recruiting · started United Kingdom
  25. Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological DiseasesNCT06387654 · Recruiting · started · Blood sampling; Remainders of samples taken as part of the treatmentFrance
  26. Registry for Systemic Eczema TreatmentsNCT06136767 · Recruiting · started United States
  27. CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness RegistryNCT06238765 · Recruiting · started United States
  28. A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab TreatmentNCT06192563 · Recruiting · started · DupilumabItaly (9)
  29. Collection of Samples From Subjects With Various Skin Conditions and Healthy VolunteersNCT05994976 · Recruiting · started · Blood samples collection; Oral samples collection; Hair samples collection; Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping)Canada
  30. Drug Survival of Target Therapies in Atopic DermatitisNCT06882148 · Recruiting · started · target therapies (biological drug, small molecules)Italy
  31. Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control PopulationNCT06259669 · Recruiting · started · Ruxolitinib CreamUnited States
  32. A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their OffspringNCT05721937 · Recruiting · started · AbrocitinibUnited States
  33. Determinants of Chronic Inflammatory Skin Disease TrajectoriesNCT05928169 · Recruiting · started · Topical and systemic drugsGermany
  34. An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database AnalysisNCT06627335 · Recruiting · started · Ruxolitinib Cream; TCSUnited States
  35. Mind and Skin - the Neurocutaneous Axis in Atopic EczemaNCT05790330 · Recruiting · started · Methotrexate; DupilumabUnited Kingdom
  36. A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.NCT05689151 · Recruiting · started · AbrocitinibFrance (30)
  37. Multi-modal Quantitative Imaging of the SkinNCT06989216 · Recruiting · started Sweden (3)
  38. A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic DermatitisNCT05391061 · Recruiting · started · AbrocitinibSouth Korea
  39. ADBest TREAT RegistryNCT07904546 · Recruiting · started · Abrocitinib; Baricitinib; Upadacitinib; DupilumabGermany
  40. Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECTNCT05938478 · Recruiting · started · TralokinumabUnited States

Showing the 40 most recent of 76. See every one on ClinicalTrials.gov.

Source: ClinicalTrials.gov, fetched 2026-11-10.

Where to go

Institutions running these trials, by country. The country picker in the trials section narrows this list too.

🇺🇸United States519

New York

  • Nektar Investigative Site 1
  • Sadick Research Group, LLC 1
  • Icahn School of Medicine at Mount Sinai 1
  • Enveda Investigative Site 1
  • Inmagene Site 21 1
  • Investigational Site 1
  • New York University Langone Health: Department of Pediatric Allergy and Immunology 1
  • Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology 1
  • OptiSkin Medical 1
  • Weill Cornell Medicine 1
  • Columbia University Irving Medical Center 1
  • The Skin Center Dermatology Group 1
  • Galderma Investigational Site - 7051 1
  • Galderma Investigational Site 7109 1
  • Galderma Investigational Site 8279 1
  • Pfizer 1
  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital 1
  • Greenwich Village Dermatology 1

Birmingham

  • Cahaba Dermatology & Skin Health Center 3
  • AllerVie Clinical Research 2
  • Cahaba Dermatology & Skin Health Center, LLC 2
  • Arcutis Site 324 1
  • Nektar Investigative Site 1
  • Leo Pharma Investigational site 1
  • Cahaba Dermatology and Skin Health Center 1
  • Enveda Investigative Site 1
  • Novartis Investigative Site 1
  • Cahaba Dermatology & Skin Health Center- Site Number : 8400006 1
  • Galderma Investigational Site - 8893 1

Los Angeles

  • California Allergy & Asthma Medical Group 1
  • Nektar Investigative Site 1
  • Triveni Bio Site #4 1
  • Enveda Investigative Site 1
  • Metropolis Dermatology 1
  • Dermatology Research Associates 1
  • University of California Los Angeles 1
  • Metropolis Dermatology - DTLA 1
  • Inmagene Site 23 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • California Allergy and Asthma Medical Group 1
  • James Y. Wang MD, Inc 1
  • Dermatology Research Associates - Los Angeles- Site Number : 8400020 1
  • Galderma Investigational Site 7099 1

Miami

  • Research Associates of South Florida, LLC 1
  • Pediatric Skin Research 1
  • Leo Pharma Investigational site 1
  • Triveni Bio Site #7 1
  • Triveni Bio Site #3 1
  • Quality Care Clinical Research 1
  • FXM Clinical Research Miami, LLC 1
  • Enveda Investigative Site 1
  • Skin Research of South Florida 1
  • Novartis Investigative Site 1
  • Florida International Research Center 1
  • Clinical Site 112 1
  • Clinical Site 110 1
  • Miami Dermatology and Laser Research 1
  • Galderma Investigational Site 7078 1

San Antonio

  • Texas Dermatology and Laser Specialists 3
  • Enveda Investigative Site 2
  • Triveni Bio Site #9 1
  • Triveni Bio Site #6 1
  • Texas Dermatology and Laser Specialist-San Antonio 1
  • Progressive Clinical Research, PA 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Clinical Site 104 1

San Diego

  • Investigational Drug Service - Rady Childrens Hospital-San Diego 2
  • University Clinical Trials, Inc 1
  • University of California, San Diego/ Rady Children's Hospital - San Diego 1
  • University of California, San Diego/Rady Children's Hospital-San Diego; Pediatric & Adolescent Derm 1
  • Leo Pharma Investigational site 1
  • Enveda Investigative Site 1
  • University of California, San Diego: Dermatology Clinical Trials Unit 1
  • TCR Medical Corporation 1
  • Allergy and Asthma Medical Group and Research Center 1
  • University Clinical Trials- Site Number : 8400019 1

Phoenix

  • Alliance Dermatology & MOHS Center 1
  • Nektar Investigative Site 1
  • Saguaro Dermatology Associates 1
  • Mayo Clinic Hospital 1
  • Mayo Clinic Specialty Building 1
  • U.S. Dermatology Partners 1
  • Saguaro Dermatology- Site Number : 8400028 1
  • Galdrma Investigational Site - 7077 1
  • Galderma Investigational Site 7060 1
  • Galderma Investigational Site - 8535 1

San Francisco

  • San Francisco VA Medical Center 3
  • UCSF Mt Zion Campus 3
  • University of California, San Francisco 2
  • Power Life Sciences 1

Dallas

  • Derm Texas 2
  • Dermatology Treatment and Research Center 1
  • Enveda Investigative Site 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Clinical Investigations of Texas 1
  • Reveal Research Institute - Dallas- Site Number : 8400012 1
  • Galderma Investigational Site 8238 1

Bethesda

  • National Institutes of Health Clinical Center 8

Sacramento

  • Integrative Skin Science and Research 2
  • Nektar Investigative Site 1
  • Leo Pharma Investigational site 1
  • Novartis Investigative Site 1
  • Physioseq, LLC /ID# 267266 1
  • University of California, Davis Health, Department of Dermatology 1

Fountain Valley

  • First OC Dermatology Research Inc 1
  • Nektar Investigative Site 1
  • Triveni Bio Site #15 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • First OC Dermatology 1
  • Galderma Investigational Site 8636 1

Tampa

  • Advanced Clinical Research Institute 1
  • Nektar Investigative Site 1
  • Leo Pharma Investigational site 1
  • NMC Research LLC 1
  • Inmagene Site 4 1
  • True Blue Clinical Research 1
  • Galderma Investigational Site 7054 1

Indianapolis

  • Dawes Fretzin Clinical Research Group, LLC 4
  • Triveni Bio Site #2 1
  • Enveda Investigative Site 1
  • Galderma Investigational Site 8142 1

The Bronx

  • Nektar Investigative Site 1
  • Montefiore - Jacobi Dermatology Clinic 1
  • Montefiore - Clinical Research Center 1
  • Montefiore - Greene Medical Arts Pavillion 1
  • Montefiore - The Dermatology Center 1
  • Montefiore Medical Center 1
  • Equity Medical, LLC 1

Northridge

  • Northridge Clinical Trials 3
  • Northridge Clinical Trials, LLC 1
  • Enveda Investigative Site 1
  • Northridge Clinical Trials, LLC- Site Number : 8400009 1

North Little Rock

  • Arkansas Research Trials 4
  • Nektar Investigative Site 1
  • Leo Pharma Investigational site 1

Charleston

  • Medical University of South Carolina - South Carolina Translational Research Nexus Clinic 2
  • Medical University of South Carolina - Department of Dermatology 1
  • Medical University of South Carolina - Walton Research Building 1
  • Leo Pharma Investigational site 1
  • Investigational Site 1

Philadelphia

  • Paddington Testing Co, Inc 1
  • Sitryx Clinical Site 1
  • Paddington Testing Company 1
  • University of Pennsylvania 1
  • Galderma Investigational Site 8559 1
  • Galderma Investigational Site 7103 1

Chicago

  • Lurie Children's Hospital/Northwestern University 1
  • Arcutis Site 320 1
  • Enveda Investigative Site 1
  • Northwestern University Feinberg School of Medicine: Department of Dermatology 1
  • Galderma Investigational Site 7058 1

Macon

  • Skin Care Physicians of Georgia 1
  • Nektar Investigative Site 1
  • Leo Pharma Investigational site 1
  • Novartis Investigative Site 1
  • Skin Care Physicians of Georgia - Macon- Site Number : 8400034 1

Troy

  • Revival Research Institute, LLC 2
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Galderma Investigational Site 7072 1

Camp Hill

  • Best Skin Research, LLC 2
  • Triveni Bio Site #1 1
  • Enveda Investigative Site 1
  • DermDox Centers for Dermatology 1

Fargo

  • Red River Research Partners LLC 1
  • Red River Research Partners, LLC 1
  • Inmagene Site 10 1
  • Red River Research Partners 1
  • Red River Research Partners - Fargo- Site Number : 8400037 1

Las Vegas

  • Nektar Investigative Site 1
  • Enveda Investigative Site 1
  • Las Vegas Dermatology 1
  • Las Vegas Dermatology- Site Number : 8400002 1
  • Galderma Investigational Site 8848 1

Pittsburgh

  • UPMC Department of Dermatology 2
  • Investigational Site 1
  • UPMC - Department of Dermatology- Site Number : 8400024 1
  • University of Pittsburgh Medical Center 1

Fremont

  • Enveda Investigative Site 1
  • Center for Dermatology Clinical Research, Inc. 1
  • Sitryx Clinical Site 1
  • Center for Dermatology Clinical Research- Site Number : 8400014 1
  • Galderma Investigational Site 8224 1

Ann Arbor

  • University of Michigan 2
  • University of Michigan Health System - Ann Arbor /ID# 267275 1
  • David Fivenson, MD, Dermatology, PLLC- Site Number : 8400017 1

Portland

  • Oregon Medical Research Center 1
  • Leo Pharma Investigational site 1
  • Inmagene Site 3 1
  • Investigational Site 1

Arlington

  • Arlington Research Center 1
  • Alexandria Associates in Dermatology 1
  • Enveda Investigative Site 1
  • Novartis Investigative Site 1

Sugar Land

  • Complete Dermatology 1
  • Enveda Investigative Site 1
  • Complete Dermatology - Sugar Land- Site Number : 8400001 1
  • Galderma Investigational Site 7069 1

St. Petersburg

  • GCP Research , Global Clinical Professionals 1
  • Nektar Investigative Site 1
  • Novartis Investigative Site 1
  • Galderma Investigational Site 7090 1

Columbus

  • Nektar Investigative Site 1
  • ClinOhio Research Services 1
  • Inmagene Site 9 1
  • AMR Clinical - Columbus, OH 1

Boca Raton

  • Nektar Investigative Site 1
  • Triveni Bio Site #11 1
  • Enveda Investigative Site 1
  • Galderma Investigational Site 8597 1

Auburn Hills

  • Nektar Investigative Site 1
  • Enveda Investigative Site 1
  • Oakland Hills Dermatology- Site Number : 8400042 1
  • Galderma Investigational Site 7066 1

Jacksonville

  • Solutions Through Advanced Research 2
  • Leo Pharma Investigational site 1
  • Investigational Site 1

Santa Monica

  • Enveda Investigative Site 1
  • Clinical Science Institute 1
  • Novartis Investigative Site 1
  • Galderma Investigational Site 7064 1

Portsmouth

  • Novartis Investigative Site 1
  • StracSkin, PLLC 1
  • Optima Research Portsmouth- Site Number : 8400032 1
  • Galderma Investigational Site 7055 1

Winston-Salem

  • Wake Forest University Health Sciences 2
  • Wake Forest University Health Sciences- Site Number : 8400003 1

Houston

  • Advanced Dermatology 1
  • Enveda Investigative Site 1
  • Novartis Investigative Site 1

Bryant

  • Arcutis Site 337 1
  • Dermatology Trial Associates, Inc. 1
  • Dermatology Trial Associates, Inc 1

Bakersfield

  • Kern Research, Inc. 2
  • Kern Research, Inc.- Site Number : 8400047 1

Huntington Beach

  • Marvel Clinical Research 2
  • Marvel Research, LLC 1

Southlake

  • Stryde Research-Epiphany Dermatology 2
  • Inmagene Site 8 1

West Hills

  • Focus Clinical Research 1
  • Enveda Investigative Site 1
  • Alliance Clinical, Focus Clinical Research 1

Savannah

  • Aeroallergy Research Laboratories of Savannah, Inc 1
  • Nektar Investigative Site 1
  • Georgia Skin & Cancer Center 1

Lee's Summit

  • Nektar Investigative Site 1
  • U.S. Dermatology Partners Lee's Summit 1
  • Galderma Investigational Site 7057 1

Wilmington

  • Nektar Investigative Site 1
  • Enveda Investigative Site 1
  • Investigational Site 1

Meridian

  • Ada West Research - Meridian 1
  • Ada West Research 1
  • Ada West Research, LLC 1

Norfolk

  • Leo Pharma Investigational site 1
  • Enveda Investigative Site 1
  • Virginia Clinical Research, Inc 1

Bay City

  • Triveni Bio Site #13 1
  • Enveda Investigative Site 1
  • Great Lakes Research Group - Bay City- Site Number : 8400052 1

Boardman

  • Triveni Bio Site #16 1
  • Investigational Site 1
  • Sitryx Clinical Site 1

Plainfield

  • Enveda Investigative Site 1
  • Clinical Site 106 1
  • Sitryx Clinical Site 1

North Miami Beach

  • Ziaderm Research LLC 1
  • Ziaderm Research, LLC- Site Number : 8400021 1
  • Galderma Investigational Site 7070 1

Mayfield Heights

  • Enveda Investigative Site 1
  • Apex Clinical Research Center, LLC. 1
  • Inmagene Site 5 1

Rockville

  • Investigational Site 1
  • U.S. Dermatology Partners Rockville 1
  • Galderma Investigational Site 7068 1

Bountiful

  • Sitryx Clinical Site 1
  • Cope Family Medicine - Ogden Clinic- Site Number : 8400053 1
  • Galderma Investigational Site 7085 1

Waltham

  • CorEvitas, LLC 3

Caledonia

  • Derm Research Institute, PLC 1
  • The Derm Institute of West Michigan- Site Number : 8400025 1
  • Galderma Investigational Site 7071 1

Boston

  • Boston Children's Hospital 2

Vienna

  • Forefront Dermatology - Vienna 1
  • Galderma Investigational Site 7079 1

Miami Lakes

  • Arcutis Site 321 1
  • Global Health Research Center, Inc. 1

Santa Ana

  • Wolverine Clinical Trials 1
  • Novartis Investigative Site 1

Marietta

  • Marietta Dermatology Clinical Research, Inc. 2

Boise

  • Treasure Valley Medical Research 1
  • Nektar Investigative Site 1

East Syracuse

  • Empire Dermatology 1
  • Galderma Investigational Site # 7052 1

Tulsa

  • Vital Prospects Clinical Research Institute., PC 1
  • Leo Pharma Investigational site 1

Scottsdale

  • ORSO Health 1
  • Mayo Clinic 1

Kirksville

  • Nektar Investigative Site 1
  • Cleaver Dermatology- Site Number : 8400033 1

Normal

  • Nektar Investigative Site 1
  • Sneeze, Wheeze, & Itch Associates, LLC- Site Number : 8400029 1

Bowling Green

  • Nektar Investigative Site 1
  • Investigational Site 1

Clifton

  • Nektar Investigative Site 1
  • Trail Horizon 1

St Louis

  • Saint Louis University 1
  • Saint Louis University - Department of Dermatology 1

Greenville

  • Tribe Clinical Research, LLC 2

Waterford

  • Leo Pharma Investigational site 1
  • Michigan Dermatology Institute - Waterford- Site Number : 8400013 1

Wheat Ridge

  • Paradigm Clinical Research Centers, LLC: Wheat Ridge 1
  • Western States Clinical Research, Inc.- Site Number : 8400051 1

Hollywood

  • Skin Care Research 1
  • Galderma Investigational Site 7134 1

Skokie

  • Endeavor Health 1
  • Investigational Site 1

Clarksville

  • DS Research of Southern Indiana,LLC 1
  • Enveda Investigative Site 1

Atlanta

  • Enveda Investigative Site 1
  • Novartis Investigative Site 1

West Lafayette

  • Enveda Investigative Site 1
  • Galderma Investigational Site 7083 1

Louisville

  • Enveda Investigative Site 1
  • Novartis Investigative Site 1

Margate

  • Gsi Clinical Research 1
  • Investigational Site 1

Brighton

  • Novartis Investigative Site 1
  • Galderma Investigational Site 7065 1

Coral Gables

  • Investigational Site 1
  • Galderma Investigational Site 7087 1

Detroit

  • Investigational Site 1
  • Wayne State University - Detroit Medical Center- Site Number : 8400035 1

Mason

  • Investigational Site 1
  • Dermatologists of Southwest Ohio - Mason- Site Number : 8400050 1

Mill Creek

  • Investigational Site 1
  • Frontier Dermatology Partners CRO LLC- Site Number : 8400011 1

South Jordan

  • Clinical Site 109 1
  • Jordan Valley Dermatology 1

Rochester

  • University of Rochester Medical Center: Department of Dermatology 1
  • University of Rochester Medical Center 1

Morgantown

  • West Virginia Research Institute 1
  • Galderma Investigational Site 8725 1

Morrisville

  • Syneos Health (remote site) 2

East Windsor

  • Eczema Treatment Center of New Jersey 1

Mobile

  • Advanced Dermatology & Skin Care Centre 1

Crest Hill

  • Premier Dermatology 1

Libertyville

  • Lakeside Dermatology 1

Grand Rapids

  • Forefront Dermatology - Grand Rapids 1

City of Saint Peters

  • Forefront Dermatology - St. Peters 1

Greensburg

  • Forefront Dermatology - Greensburg 1

Fairfax

  • Forefront Dermatology - Fairfax 1

Virginia Beach

  • Forefront Dermatology - Virginia Beach 1

Laguna Niguel

  • Avance Clinical Trials 1

Hialeah

  • Direct Helpers Research Center 1

Orlando

  • Clinical Neuroscience Solutions, LLC 1

Hunt Valley

  • Maryland Laser Skin and Vein 1

Ypsilanti

  • Respiratory Medicine Research Institute of Michigan, PLC 1

Memphis

  • Clinical Neuroscience Solutions, LLC. 1

Panama City

  • AllerVie Clinical Research 1

Oxnard

  • Nektar Investigative Site 1

Palmdale

  • Nektar Investigative Site 1

Tamarac

  • Nektar Investigative Site 1

Metairie

  • Nektar Investigative Site 1

Robbinsville

  • Nektar Investigative Site 1

Owensboro

  • Nektar Investigative Site 1

Lafayette

  • Nektar Investigative Site 1

Omaha

  • Nektar Investigative Site 1

Oklahoma City

  • Nektar Investigative Site 1

Palo Alto

  • Leo Pharma Investigational site 1

Irving

  • ALS Global 1

Myrtle Beach

  • Triveni Bio Site #14 1

Spokane

  • Triveni Bio Site #8 1

Encinitas

  • Enveda Investigative Site 1

Tarzana

  • Valiance Clinical Research - Tarzana 1

Cape Coral

  • ABMED Clinical Research Corp. 1

North Lauderdale

  • Eminent Clinical Research and Associates 1

Pasadena

  • Chesapeake Clinical Research, Inc 1

Reno

  • Skin Cancer and Dermatology Institute 1

South San Francisco

  • Corvus Clinical Trials 1

Hot Springs

  • Enveda Investigative Site 1

Beverly Hills

  • Enveda Investigative Site 1

Fort Lauderdale

  • Enveda Investigative Site 1

Miramar

  • Enveda Investigative Site 1

New Albany

  • Enveda Investigative Site 1

Clinton Township

  • Enveda Investigative Site 1

Warren

  • Enveda Investigative Site 1

Canton

  • Enveda Investigative Site 1

Lorain

  • Apex Clinical Research Center, LLC. - Lorain 1

Lancaster

  • Inmagene Site 1 1

Ocala

  • Inmagene Site 19 1

Rolling Meadows

  • Inmagene Site 2 1

Kew Gardens

  • Inmagene Site 6 1

Woodbury

  • Inmagene Site 11 1

Charlotte

  • Inmagene Site 20 1

Anderson

  • Inmagene Site 12 1

Burien

  • Inmagene Site 7 1

Fort Smith

  • Novartis Investigative Site 1

Washington D.C.

  • Novartis Investigative Site 1

Saint Joseph

  • Novartis Investigative Site 1

Brooklyn

  • Novartis Investigative Site 1

Cypress

  • Novartis Investigative Site 1

Douglasville

  • Investigational Site 1

Nashville

  • Investigational Site 1

Frisco

  • Investigational Site 1

Bellaire

  • UT Health Science Houston 1

Webster

  • Center for Clinical Studies 1

Weston

  • Encore Medical Research of Weston LLC 1

Union City

  • Rophe Adult and Pediatric Medicine 1

North Charleston

  • National Allergy and Asthma Research, LLC 1

Fair Lawn

  • Clinical Site 101 1

College Station

  • Clinical Site 102 1

Denver

  • National Jewish Health: Division of Pediatric Allergy and Clinical Immunology 1

Cincinnati

  • Cincinnati Children's Hospital Medical Center: Asthma Center 1

Madison

  • University of Wisconsin School of Medicine and Public Health: Division of Pediatric Allergy, Immunology and Rheumatology 1

Irvine

  • First OC Dermatology 1

Arkansas City

  • Sitryx Clinical Site 1

Anaheim

  • Anaheim Clinical Trials, LLC 1

Austin

  • Seeding Labs INC 1

Henderson

  • Advanced Dermatology and Cosmetic Surgery - Henderson 1

Longview

  • DCOL Center for Clinical Research 1

Missouri City

  • Harrison Dermatology 1

Montgomery

  • River Region Dermatology and Laser- Site Number : 8400041 1

Gilbert

  • San Tan Allergy & Asthma- Site Number : 8400031 1

Oakland

  • Sunwise Clinical Research, LLC.- Site Number : 8400010 1

Pomona

  • Empire Clinical Research, LLC- Site Number : 8400007 1

Doral

  • St. Jude Clinical Research- Site Number : 8400049 1

North Chicago

  • Rosalind Franklin University of Medicine and Science- Site Number: 8400056 1

Bolivar

  • Red River Research Partners, Llc- Site Number : 8400054 1

Lincoln

  • Allergy Asthma & Immunology- Site Number : 8400044 1

Albuquerque

  • University Of New Mexico School Of Medicine- Site Number : 8400022 1

Huntersville

  • Piedmont Plastic Surgery and Dermatology- Site Number : 8400038 1

Marion

  • Dermatology Associates of Mid-Ohio- Site Number : 8400026 1

Warwick

  • Care Access Research - Warwick 2- Site Number : 8400045 1

Spartanburg

  • Advanced Dermatology and Cosmetic Surgery - Spartanburg- Site Number : 8400004 1

Fort Worth

  • Innovate Research - Fort Worth- Site Number : 8400016 1

Pflugerville

  • Austin Institute for Clinical Research, Inc- Site Number : 8400030 1

Springville

  • Springville Dermatology - Springville- Site Number : 8400055 1

Falls Church

  • Fuchs Dermatology- Site Number : 8400027 1

Seattle

  • University of Washington - Roosevelt Location- Site Number : 8400005 1

Tucson

  • Galderma Investigational Site - 7067 1

Corona

  • Galderma Investigational Site - 7074 1

Newport Beach

  • Galderma Investigational Site 8553 1

Thousand Oaks

  • Galderma Investigational Site 7107 1

Castle Rock

  • Galderma Investigational Site 7061 1

Fairfield

  • Galderma Investigational Site 7059 1

Cutler Bay

  • Galderma Investigational Site 7063 1

Jupiter

  • Galderma Investigational Site 7101 1

Oakland Park

  • Galderma Investigational Site 7112 1

Columbia

  • Galderma Investigational Site 7098 1

Glenn Dale

  • Galderma Investigational Site 8012 1

Milford

  • Galderma Investigationa Site 7104 1

Grandville

  • Galderma Investigational Site 7108 1

Auburn

  • Galderma Investigational Site - Site 7080 1

Mount Kisco

  • Galderma Investigational Site - 8282 1

Dayton

  • Galderma Investigational Site 7081 1

Gresham

  • Galderma Investigational Site 7073 1

Bluffton

  • Galderma Investigational Site 7106 1

Cedar Park

  • Galderma Investigational Site 7082 1

Edinburg

  • Galderma Investigational Site 7062 1

Grapevine

  • Galderma Investigational Site 7088 1

Waco

  • Galderma Investigational Site 8618 1

Baltimore

  • Johns Hopkins University 1

La Jolla

  • University of California San Diego (UCSD) 1
🇨🇳China234

Beijing

  • Peking University People's Hospital 10
  • Peking University Third Hospital 3
  • Beijing Children's hospital, Capital Medical University 2
  • Peking University First Hospital 2
  • Beijing Tongren Hospital, Capital Medical University 2
  • Beijing Children's Hospital Capital Medical University 2
  • Beijing Children's Hospital, Capital Medical University 1
  • Beijing Friendship Hospital, Capital Medical University 1
  • Capital Medical University Affiliated Beijing Chaoyang Hospital 1
  • Capital Medical University Affiliated Beijing Friendship Hospital 1
  • Beijing Tsinghua Changgung Hospital 1
  • China-japan Friendship Hospital 1
  • Peking University People's hospital 1
  • Novartis Investigative Site 1
  • Beijing Huairou Hospital 1
  • China-Japan Friendship Hospital 1
  • Beijing GoBroad Hospital 1
  • Peking University Third Hospital-Site Number: 1560008 1

Shanghai

  • Huashan Hospital, Fudan University 4
  • Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine 3
  • Shanghai Skin Disease Hospital 3
  • Shanghai Children's Hospital 2
  • Shanghai Dermatology Hospital 2
  • Shanghai Tenth People's Hospital 1
  • Shanghai First People's Hospital 1
  • Longhua Hospital Shanghai University of Traditional Chinese Medicine 1
  • Novartis Investigative Site 1
  • RenJi Hospital 1
  • Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine 1
  • Huashan Hospital Affiliated to Fudan University 1
  • Shanghai General Hospital 1
  • Shanghai China-norm Quality Technical Service Co., Ltd. 1
  • Huashan Hospital, Fudan University-Site Number: 1560012 1

Hangzhou

  • Hangzhou First People's Hospital 6
  • Hangzhou Third People's Hospital 3
  • Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University 2
  • Galderma Investigational Site #6431 1
  • Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine 1
  • The Second Affiliated Hospital, Zhejiang University School of Medicine 1
  • The Third People's Hospital of Hangzhou 1
  • Novartis Investigative Site 1
  • Hangzhou No.1 People's Hospital 1
  • Zhejiang Provincial People's Hospital 1
  • Affiliated Hangzhou First People's Hospital, School of Medicine , West Lake University 1
  • The Second Affiliated Hospital of Zhejiang University School of Medicine 1
  • Hangzhou First People's Hospital; 1
  • Hangzhou First People's Hospital-Site Number: 1560004 1
  • The Second Affiliated Hospital of Zhejiang University School of Medicine-Site Number: 1560007 1

Guangzhou

  • Dermatology Hospital of Southern Medical University 4
  • The Second Affiliated Hospital of Guangzhou Medical University 2
  • Dermatology Hospital, Southern Medical University 1
  • Southern Medical University Dermatology Hospital Medicine 1
  • Zhongshan University Sun Yat-sen Memorial Hospital 1
  • Nanfang Hospital, Southern Medical University 1
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University 1
  • The First Affiliated Hospital of Jinan University 1
  • Guangdong Province Dermatology Hospital 1
  • Novartis Investigative Site 1
  • Southern Medical University Dermatology Hospital 1

Changsha

  • Hunan Children's Hospital 4
  • The Second Xiangya Hospital of Central South University 2
  • Central South University Xiangya Hospital 1
  • XiangYa Hospital CentralSouth University 1
  • Novartis Investigative Site 1
  • Hunan Pediatric Medical Union 1
  • Xiangya Hospital Central South University 1
  • Xiangya Hospital of Central South University-Site Number : 1560001 1
  • The Second Xiangya Hospital of Central South University-Site Number: 1560014 1

Shenyang

  • The First Hospital of China Medical University 3
  • The First Affiliated Hospital of China Medical University 2
  • Shenyang Hospital of Integrated Traditional Chinese and Western Medicine （Shenyang Seventh People's Hospital） 1
  • Zhongyi Northeast International Hospital Co., Ltd. 1
  • The First Hospital Of China Medical University 1
  • Affiliated Central Hospital of Shenyang Medical College 1
  • Shenyang Hospital of Integrated Traditional Chinese and Western Medicine 1

Nanchang

  • Dermatology Hospital of Jiangxi Province 4
  • Jiangxi Provincial Dermatology Hospital 2
  • Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine 1
  • The First Affiliated Hospital of Nanchang University 1

Chengdu

  • Sichuan Provincial People's Hospital 3
  • Chengdu Second People's Hospital 1
  • West China Hospital Sichuan University 1
  • West China Hospital of Sichuan University 1
  • West China Hospital, Sichuan University 1
  • West China Hospital, Sichuan University- Site Number: 1560003 1

Shenzhen

  • Shenzhen Children's Hospital 2
  • The University of Hong Kong - Shenzhen Hospital 2
  • Shenzhen Second People's Hospital 1
  • Peking University Shenzhen Hospital 1
  • The Eighth Affiliated Hospital, Sun Yat-sen University-Site Number: 1560006 1

Jinan

  • Qilu Hospital of Shandong University 2
  • Shandong Provincial Dermatology Hospital 2
  • Shandong Provincial Dermatosis Hospital 1
  • Shandong Provincial Hospital for Skin Diseases 1

Chongqing

  • The First Affiliated Hospital of Chongqing Medical University 2
  • Chongqing Traditional Chinese Medicine Hospital 2
  • The First Affiliated Hospital of Chongqing Medical University-Site Number : 1560011 1

Fuzhou

  • The First Affiliated Hospital of Fujian Medical University 3
  • The Affiliated Union Hospital of Fujian Medical University 1
  • First Affiliated Hospital of Fujian Medical University 1

Nanjing

  • Chinese Academy of Medical Sciences Hospital for Skin Disease 1
  • Chinese Academy of Medical Sciences Hospital for Skin Diseases 1
  • Sir Run Run Hospital, Nanjing Medical University 1
  • Zhongda Hospital, Southeast University 1

Wuhan

  • Wuhan Central Hospital 1
  • Wuhan Hospital of Traditional Chinese and Western Medicine (Wuhan No.1 Hospital) 1
  • Tongji Hospital 1
  • Wuhan No.1 Hospital 1

Wuhu

  • The Second Affiliated Hospital of Wannan Medical College 3

Changchun

  • The First Hospital of Jilin University 2
  • Novartis Investigative Site 1

Xi'an

  • Shaanxi Provincial People's Hospital 2
  • The First Affiliated Hospital of Xi'an Jiaotong University 1

Tianjin

  • General Hospital of Tianjin Medical University 1
  • Affiliated Hospital of Tianjin Academy of Traditional Chinese Medicine 1
  • Tianjin Medical University General Hospital 1

Ningbo

  • The First Affiliated Hospital of Ningbo University 1
  • Ning Bo No.2 Hospital 1
  • The First Affiliated Hospital of Ningbo University-Site Number : 1560009 1

Zhenjiang

  • Affiliated Hospital of Jiangsu University 2
  • Jiangsu University Affiliated Hospital 1

Hefei

  • The First Affiliated Hospital of Anhui Medical University 1
  • The Second Hospital of Anhui Medical Univesity 1

Liuzhou

  • Liuzhou People's Hospital 1
  • Liuzhou Worker's Hospital 1

Shijiazhuang

  • Second Affiliated Hospital of Hebei Medical University 1
  • Hebei Medical University Second Hospital 1

Zhengzhou

  • Henan Provincial People's Hospital 1
  • Zhengzhou Central Hospital 1

Jining

  • Jining First People's Hospital 2

Kunming

  • The First Affiliated Hospital of Kunming Medical University 2

Wenzhou

  • The First Affiliated Hospital of Wenzhou Medical University 1
  • The Second Affiliated Hospital of Wenzhou Medical University 1

Dongguan

  • Dongguan People's Hospital 2

Xi’an

  • The First Affiliated Hospital of Xi'an Jiao Tong University 1
  • The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital)-Site Number: 1560002 1

Suzhou

  • Suzhou Municipal Hospital 1
  • The First Affiliated Hospital of Soochow University 1

Jinhua

  • The Fourth Affiliated Hospital Zhejiang University School of Medicine 1

Xiamen

  • The Second Affiliated Hospital of Xiamen Medical College 1

Shaoguan

  • Yuebei People's Hospital 1

Chengde

  • Affiliated Hospital of Chengde Medical University 1

Handan

  • Affiliated Hospital of Hebei University of Engineering 1

Luoyang

  • The Second Affiliated Hospital of Henan University of Science and Technology 1

Sanmenxia

  • Sanmenxia Central Hospital 1

Jingzhou

  • Jingzhou Central Hospital 1

Hohhot

  • The Affiliated Hospital of Inner Mongolia Medical University 1

Changzhou

  • Changzhou First People's Hospital 1

Yancheng

  • Yancheng First People's Hospital 1

Ganzhou

  • The First Affiliated Hospital of Gannan Medical University 1

Jiujiang

  • Affiliated Hospital of Jiujiang University 1

Qingdao

  • The Affiliated Hospital of Qingdao University 1

Yuncheng

  • Yuncheng Central Hospital 1

Yiwu

  • The Fourth Affiliated Hospital, Zhejiang University School of Medicine 1

Jiangmen

  • Jiangmen Central Hospital 1

Zhuhai

  • The Third People's Hospital of Zhuhai 1

Jinzhou

  • Jinzhou Central Hospital 1

Jiaxing

  • The First Hospital of Jiaxing 1

Shantou

  • Novartis Investigative Site 1

Haikou

  • Hainan Provincial Fifth People's Hospital 1

Tangshan

  • Affiliated Hospital of North China University of Science and Technology 1

Shiyan

  • Shiyan People's Hospital 1

Yinchuan

  • General Hospital of Ningxia Medical University 1

Binzhou

  • Affiliated Hospital of Binzhou Medical University 1

Wuxi

  • Wuxi Second People's Hospital 1
🇩🇪Germany88

Berlin

  • Investigational Site 1
  • Parexel EPCU Berlin 1
  • Sitryx Clinical Site 1
  • Charite-Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) 1
  • Galderma Investigational Site 6385 1
  • Galderma Investigative Site 6172 1
  • Galderma Investigational Site 6366 1
  • Dpt of Dermatology and Allergology, Charité - Universitätsmedizin Berlin 1

Dresden

  • Universitaetsklinikum Carl Gustav Carus, Technischen Universitaet Dresden 1
  • Leo Pharma Investigational site 1
  • University Hospital Dresden 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Department of Dermatology, UniversityAllergyCenter, Medical Faculty Carl Gustav Carus, TU Dresden 1

Kiel

  • Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel 2
  • University Hospital Schleswig-Holstein 1
  • Investigational Site 1
  • Department of Dermatology and Allergy, University Hospital Schleswig-Holstein 1
  • Head Centre for Inflammatory Skin Diseases, Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel 1

Münster

  • Universitätsklinikum Münster 2
  • University Hospital of Muenster 1
  • Novartis Investigative Site 1
  • Investigational Site 1

Hamburg

  • Dermatologikum Hamburg GmbH 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Institute for Health Services Research in Dermatology and Nursing, IVDP; University Medical Center Hamburg-Eppendorf,UKE 1

Lübeck

  • University of Luebeck 1
  • Universitätsklinikum Schleswig-Holstein 1
  • CCIM, Institut für Entzündungsmedizin UKSH Lübeck 1
  • Galderma Investigational Site 6013 1

Augsburg

  • Investigational Site 1
  • Department of Dermatology of the University Hospital Augsburg 1
  • Galderma Investigational Site 6416 1
  • Galderma Investigational Site 6383 1

Freiburg im Breisgau

  • Alm Site 1 1
  • Investigational Site 1
  • Sitryx Clinical Site 1

Mainz

  • Leo Pharma Investigational site 1
  • Novartis Investigative Site 1
  • Galderma Investigational Site 6373 1

Bad Bentheim

  • Fachklinik Bad Bentheim 1
  • Novartis Investigative Site 1
  • Investigational Site 1

Frankfurt

  • Universitatsklinikum Frankfurt Klinik fur Dermatologie, Venerologie und Allergologie 1
  • Sitryx Clinical Site 1
  • Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Frankfurt 1

Hanover

  • Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Clinical Airway Research 1
  • Hannover Medical School, Department of Dermatology and Allergy 1
  • Clinics for Dermatology, Allergy and Venerology, Hannover Medical School 1

Buxtehude

  • Leo Pharma Investigational site 1
  • Galderma Investigational Site 6066 1

Tübingen

  • Leo Pharma Investigational site 1
  • Investigational Site 1

Frankfurt am Main

  • Novartis Investigative Site 1
  • Investigational Site 1

Heidelberg

  • Novartis Investigative Site 1
  • Investigational Site 1

Osnabrück

  • Leo Pharma Investigational site 1

Wuppertal

  • Leo Pharma Investigational site 1

Witten

  • Hautarztpraxis Dr. Hoffmann 1

Magdeburg

  • Novartis Investigative Site 1

Oldenburg

  • Novartis Investigative Site 1

München

  • Investigational Site 1

Blankenfelde-Mahlow

  • Investigational Site 1

Darmstadt

  • Investigational Site 1

Düsseldorf

  • Evangelisches Krankenhaus Düsseldorf - Frauenklinik 1

Spandau

  • Evangelisches Waldkrankenhaus Spandau 1

Wesel

  • Marien Hospital Wesel GmbH 1

Karlsruhe

  • Galderma Investigational Site 6374 1

Langenau

  • Galderma Investigational Site 6412 1

Erlangen

  • Galderma Investigational Site 6369 1

Regensburg

  • Galderma Investigational Site 6417 1

Remscheid

  • Galderma Investigational Site 6419 1

Ahaus

  • Galderma Investigational Site 6387 1

Bernau bei Berlin

  • Galderma Investigational Site 6398 1

Bielefeld

  • Galderma Investigational Site 6386 1

Gladbeck

  • Galderma Investigational Site 6414 1

Großenhain

  • Galderma Investigational Site 6418 1

Haslach im Kinzigtal

  • Galderma Investigational Site 6370 1

Hersbruck

  • Galderma Investigational Site 6420 1

Koblenz

  • Galderma Investigational Site 6384 1

Oberursel

  • Galderma Investigational Site 6371 1

Oranienburg

  • Galderma Investigational Site 6411 1

Pforzheim

  • Galderma Investigational Site 6390 1

Quedlinburg

  • Galderma Investigational Site 6372 1
🇵🇱Poland81

Warsaw

  • Centrum Medyczne Evimed 2
  • Klinika Ambroziak Dermatologia 2
  • Leo Pharma Investigational site 1
  • Synexus Polska Sp. Z o.o. Odział w Warszawie 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Państwowy Instytut Medyczny MSWiA 1
  • BioMedical Centers 1

Katowice

  • Centrum Medyczne Angelius Provita 3
  • Synexus Polska Sp. z o.o. Oddzial w Katowicach 1
  • Angelius Badania Kliniczne 1
  • CM Pratia Katowice 1
  • Provita Sp. z o. o. 1
  • Novartis Investigative Site 1
  • Investigational Site 1

Lodz

  • Dermoklinika - Centrum Medyczne spółka cywilna M. Kierstan, J. Narbutt, A. Lesiak 3
  • Leo Pharma Investigational site 1
  • Synexus Polska Sp. z. o.o. Oddzial W Lodzi 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Wojewódzki Specjalistyczny Szpital im. Dr. Wł. Biegańskiego w Łodzi 1

Lublin

  • LUXDERM Specjalistyczny Gabinet Dermatologiczny prof. dr hab. n. med. Dorota Krasowska 2
  • LUXDERM Specjalistyczny Gabinet Dermatologiczny Prof. dr hab. n. med. Dorota Krasowska 1
  • Klinika Zdybski 1
  • Clinical Best Solution Sp. z o.o. 1
  • Novartis Investigative Site 1
  • Investigational Site 1

Szczecin

  • Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Królicki 2
  • Laser Clinic 1
  • Laser Clinic S.C. Andrzej Krolicki, Tomasz Kochanowski 1
  • Twoja Przychodnia Szczecinskie Centrum Medyczne Sp. z o.o. 1
  • Twoja Przychodnia - Szczecinskie Centrum Medyczne 1
  • Investigational Site 1

Krakow

  • Specjalistyczny Gabinet Dermatologiczny Aplikacyjno-Badawczy, Marek Brzewski, Paweł Brzewski spółka cywilna 2
  • Leo Pharma Investigational site 1
  • Centrum Badań Klinicznych Jagiellońskie Centrum Innowacji sp. z o.o. 1
  • Centrum Nowoczesnych Terapii Dobry Lekarz spółka z ograniczoną odpowiedzialnością 1
  • Investigational Site 1

Gdansk

  • Leo Pharma Investigational site 1
  • Synexus Polska Sp. z o.o. Oddzial w Gdansku 1
  • Dermedea Clinic 1
  • Penta Hospitals Badania Kliniczne- Gdańsk 1 1
  • Investigational Site 1
  • Eurofins Dermscan Poland 1

Wroclaw

  • Medicus Clinic 1
  • Softskin Medical Center Dr Elzbieta Wojtowicz-Prus 1
  • Investigational Site 1
  • Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spółka Partnerska 1

Ostrowiec Świętokrzyski

  • Dermedic Jacek Zdybski 2
  • Leo Pharma Investigational site 1

Chorzów

  • DERMAPOLIS Medical Dermatology Center dr n. med. Edyta Gebska 2

Rzeszów

  • Leo Pharma Investigational site 1
  • Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie 1

Poznan

  • Synexus Polska Sp z o.o. Oddzial W Poznaniu 1
  • Twoja Przychodnia Poznanskie Centrum Medyczne Sp. 1

Kielce

  • Klinika Zdybski - Dermedic (Kielce) 1
  • Dermedic Jacek Zdybski 1

Tarnów

  • Leo Pharma Investigational site 1

Częstochowa

  • Synexus Polska Sp. z o.o. in Czestochowa 1

Mikołów

  • Twoja Klinika 1

Bydgoszcz

  • NZOZ Centrum Medyczne KERmed 1

Chojnice

  • OptiTrial 1

Piotrkow Trybunalski

  • NZOZ Hipokrates 1

Sosnowiec

  • Investigational Site 1

Bialystok

  • Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny 1

Malbork

  • Private Practice 1
🇫🇷France74

Paris

  • Hopital Saint Louis 1
  • Novartis Investigative Site 1
  • Hôpital Saint Louis 1
  • Hopital Cochin 1
  • Hopital Tenon 1
  • Hopital Saint Louis (APHP) - Service Hematologic Senior 1

Rouen

  • Hopital Charles Nicolle 2
  • Novartis Investigative Site 1
  • Hôpital Charles Nicolle 1
  • Hopital Charles Nicolle Chu Rouen 1

Lille

  • Hop Claude Huriez Chu Lille 2
  • Novartis Investigative Site 1
  • Hopital Claude Huriez 1

Clermont-Ferrand

  • Centre Hospitalier universitaire (CHU) de Clermont Ferrand Hopital d'Estaing 1
  • CHU Clermont Ferrand - Hopital Gabriel Montpied 1
  • Chu Estaing 1

Nantes

  • Centre Hospitalier Universitaire De Nantes 1
  • CHU de Nantes Hôtel-Dieu 1
  • Hopital Hotel Dieu 1

Pierre-Bénite

  • Centre Hospitalier Lyon-Sud 1
  • Novartis Investigative Site 1
  • CHU Lyon Sud 1

Toulouse

  • Hopital Larrey 2
  • University Hospital 1

Brest

  • Novartis Investigative Site 1
  • CHU de Brest 1
  • CHU Brest Hopital Morvan 1

Caen

  • CHU de Caen 2
  • CHU Caen Normandie 1

Romans-sur-Isère

  • Hôpitaux Drôme Nord 1
  • Hopitaux Drome Nord-Site Number : 2500002 1
  • Ch de Romans Sur Isere 1

Bordeaux

  • Centre Hospitalier Universitaire de Bordeaux - Hopital Saint Andre 1
  • Chu Bordeaux Hopital Saint Andre 1

Lorient

  • Novartis Investigative Site 1
  • Groupe Hospitalier Bretagne Sud 1

Martigues

  • Investigational Site 1
  • CH de Martigues 1

Amiens

  • CHU Amiens Picardie 1
  • CHU Amiens-Picardie - Site Nord 1

Grenoble

  • CHU de Grenoble Alpes 1
  • Eurofins Optimed 1 rue des Essarts, 38610 Gières - France 1

Tours

  • CHRU de Tours 1
  • CHU de Tours 1

Rennes

  • CHU de Rennes 1
  • Hopital Pontchaillou 1

Besançon

  • CHU Besançon - Hôpital Jean Minjoz-Site Number: 2500010 1
  • CHU Besancon - Hopital Jean Minjoz 1

Mulhouse

  • GHRMSA - Hospital Emile Muller-Site Number : 2500006 1
  • Hopital Emile Muller 1

Chalon-sur-Saône

  • Centre Hospitalier William Morey-Site Number: 2500008 1
  • Ch William Morey 1

Reims

  • Novartis Investigative Site 1

Lyon

  • Hôpital de la Croix Rousse 1

Angers

  • CHU d'Angers 1

La Roche-sur-Yon

  • CHD Vendée 1

Vannes

  • CH Bretagne Atlantique 1

Valence

  • Centre Hospitalier de Valence-Site Number: 2500005 1

Saint-Pierre

  • CHU de La Reunion-Site Number: 2500007 1

Le Mans

  • Centre Hospitalier du Mans-Site Number: 2500004 1

Bezannes

  • Polyclinique Reims Bezannes 1

Calais

  • Ch de Calais 1

Créteil

  • Hopital Henri Mondor 1

Dijon

  • Chu Dijon 1

Levallois-Perret

  • Hopital Franco Britannique 1

Montpellier

  • CHU Montpellier 1

Saint-Germain-en-Laye

  • Chi Poissy Saint Germain En Laye 1

Saint-Mandé

  • Hopital Bégin 1

Valenciennes

  • Ch de Valenciennes 1

Vandœuvre-lès-Nancy

  • CHU Nancy 1
🇨🇦Canada59

Montreal

  • Innovaderm Research Inc 1
  • Inmagene Site 14 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • St. Justine's Hospital 1
  • CHU Sainte-Justine 1
  • Innovaderm Research Inc. 1
  • Innovaderm Research 1

Calgary

  • Leo Pharma Investigational site 1
  • Triveni Bio Site #17 1
  • Beacon Dermatology 1
  • Laser Rejuvenation Clinics Edmonton D.T. Inc. 1
  • Dermatology Research Institute 1
  • Investigational Site 1

Edmonton

  • Leo Pharma Investigational site 1
  • Laser Rejuvenation Clinics Edmonton D.T. Inc. 1
  • Rejuvenation Dermatology Clinic Edmonton South 1
  • Novartis Investigative Site 1
  • Investigational Site 1

Toronto

  • FACET Dermatology 1
  • North York Research Inc. 1
  • Toronto Research Centre 1
  • Investigational Site 1

Saskatoon

  • Leo Pharma Investigational site 1
  • Saskatoon Dermatology Centre 1
  • Inmagene Site 16 1

Mississauga

  • DermEdge Research 1
  • Inmagene Site 13 1
  • Investigational Site 1

Vancouver

  • Inmagene Site 22 1
  • Investigational Site 1
  • BC Children's Hospital 1

Hamilton

  • Leo Pharma Investigational site 1
  • Novartis Investigative Site 1

Québec

  • Centre de Recherche Saint-Louis inc. 1
  • Investigational Site 1

Markham

  • Novartis Investigative Site 1
  • Investigational Site 1

Burlington

  • Leo Pharma Investigational site 1

Niagara Falls

  • Leo Pharma Investigational site 1

Windsor

  • Leo Pharma Investigational site 1

Winnipeg

  • Leo Pharma Investigational site 1

Barrie

  • Triveni Bio Site #5 1

Sherbrooke

  • Centre de Recherche Saint-Louis (Sherbrooke) 1

Surrey

  • Inmagene Site 15 1

Greater Sudbury

  • Inmagene Site 17 1

North Bay

  • Inmagene Site 18 1

Verdun

  • Novartis Investigative Site 1

Fredericton

  • Investigational Site 1

Ajax

  • Investigational Site 1

Ottawa

  • Investigational Site 1

Peterborough

  • Investigational Site 1

Rimouski

  • SCF Pharma 1

Regina

  • Origins Dermatology Centre-Site Number : 1240003 1
🇯🇵Japan51

Sakai

  • Dermatology and Ophthalmology Kume Clinic 5
  • Izumigaoka Skin Clinic 1

Fukuoka

  • Fukuoka National Hospital 2
  • Saruta Dermatology Clinic 2
  • Novartis Investigative Site 2

Yokohama

  • Queen's square Medical Facilities Queen's square Dermatology and Allergology 3
  • Queen's Square Medical Facilities Queen's Square Medical Center, Dermatology and Allergology 1
  • Novartis Investigative Site 1

Chuo-ku

  • Nihonbashi Sakura Clinic 2
  • Fukuwa Clinic 2

Matsudo

  • Charme Clinique 1
  • Miyata Dermatology Clinic 1
  • Novartis Investigative Site 1

Nagoya

  • Japan Community Healthcare Organization Chukyo Hospital 1
  • Novartis Investigative Site 1

Habikino

  • Osaka Habikino Medical Center 1
  • Novartis Investigative Site 1

Setagaya-ku

  • Sasamoto Children's Clinic 2

Tokyo

  • Mita Dermatology Clinic 1
  • Sumire Dermatology Clinic 1

Yahaba-cho

  • Iwate Medical University Hospital 1

Shimotsuga-gun

  • Dokkyo Medical University Hospital 1

Tachikawa

  • Tachikawa Dermatology Clinic 1

Toshima-ku

  • Ikebukuro-nishiguchi Fukurou Dermatology Clinic 1

Kagoshima

  • Katahira Dermatology Urology Clinic 1

Okayama

  • Okayama University Hospital 1

Saitama

  • Pansy Skin Clinic 1

Teine-ku

  • Shibaki Dermatology Clinic 1

Nagaoka

  • Aile Home Clinic Nagaoka 1

Shinagawa

  • NTT Medical Center Tokyo 1

Osaka

  • Osaka Metropolitan University Hospital 1

Takasaki

  • Hattori Dermatology Clinic 1

Kawasaki-shi

  • Kosugi Dermatology Clinic 1

Kawasaki

  • Novartis Investigative Site 1

Shinagawa Ku

  • Novartis Investigative Site 1

Kyoto

  • Novartis Investigative Site 1

Marugame-shi

  • Takeoka Dermatology Clinic- Site Number : 3920005 1

Habikino-shi

  • Osaka Habikino Medical Center-Site Number : 3920001 1

Hamamatsu

  • JA-Shizuoka Enshu Hospital-Site Number: 3920003 1
🇪🇸Spain47

Alicante

  • Leo Pharma Investigational site 1
  • Hospital General Universitario Dr. Balmis 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Hospital General Universitario Dr. Balmis-Site Number: 7240005 1
  • Hospital General Universitario de Alicante 1

Madrid

  • Leo Pharma Investigational site 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Hospital Universitario Severo Ochoa 1
  • Hospital Infanta Leonor 1
  • Hospital Universitario de la Princesa 1

Zaragoza

  • Hospital Universitario Miguel Servet 3
  • HCU Lozano Blesa 1
  • Hospital Miguel Servet 1

Santiago de Compostela

  • CHUS - Hospital Clinico Universitario 2
  • Complejo Hospitalario Universitario de Santiago de Compostela 1
  • Investigational Site 1

Badalona

  • Hospital Universitari Germans Trias i Pujol 2
  • Novartis Investigative Site 1
  • Investigational Site 1

Barcelona

  • Hospital Quiron Salud Barcelona 1
  • Investigational Site Number : 7240006 1
  • Hospital del Mar IMIM 1

Granollers

  • Hospital General de Granollers 2

Valencia

  • Leo Pharma Investigational site 1
  • Hospital Universitario y Politécnico la Fe 1

Pontevedra

  • Novartis Investigative Site 1
  • Complexo Hospitalario Universitario de Pontevedra 1

Tarragona

  • Hospital Universitari de Tarragona Joan XXIII 1
  • Hospital Universitari Sant Joan de Reus 1

La Paz

  • Hospital Universitario La Paz 1

Granada

  • Novartis Investigative Site 1

Las Palmas GC

  • Novartis Investigative Site 1

Las Palmas de Gran Canaria

  • Investigational Site 1

A Coruña

  • Hospital Teresa Herrera 1

Almería

  • HU Torrecárdenas 1

Málaga

  • Grupo Pediátrico Uncibay 1

Seville

  • Instituto Hispalense de Pediatria (IHP) 1

Santa Cruz de Tenerife

  • Hospital Universitario de Canarias-Site Number: 7240008 1

Las Palmas

  • Hospital Universitario de Gran Canaria Dr Negrín 1
🇬🇧United Kingdom44

London

  • Leo Pharma Investigational site 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • Parexel EPCU London 1
  • Metabolic Research Unit, 4th Floor (Corridor A), Franklin-Wilkins Building, KCL. 1
  • St Thomas' Hospital 1
  • Galderma Investigational Site 5408 1
  • Galderma Investigational Site 6395 1
  • Galderma Investigational Site 5210 1
  • Galderma Investigational Site 6368 1
  • Unit for Paediatric and Population-based Dermatology Research 1

Sheffield

  • Leo Pharma Investigational site 1
  • Galderma Investigational Site 6389 1
  • Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT 1

Southampton

  • Leo Pharma Investigational site 1
  • Galderma Investigational Site 6401 1
  • University Hospitals Southampton NHS Foundation Trust 1

Dudley

  • Novartis Investigative Site 1
  • Investigational Site 1

Liverpool

  • Novartis Investigative Site 1
  • Galderma Investigational Site 6415 1

Manchester

  • Sitryx Clinical Site 1
  • Galderma Investigational Site 6396 1

Lincoln

  • Leo Pharma Investigational site 1

Salford

  • Investigational Site 1

Merthyr Tydfil

  • Sitryx Clinical Site 1

Nottingham

  • Cripps Medical Centre 1

Watford

  • Galderma Investigational Site 6399 1

Kings Lynn

  • Galderma Investigational Site 6400 1

Harrogate

  • Galderma Investigational Site 5131 1

Birmingham

  • Galderma Investigational Site 6392 1

Leeds

  • Galderma Investigational Site 6404 1

York

  • Galderma Investigational Site 6397 1

Bridgend

  • Galderma Investigational Site 6375 1

Epsom

  • Galderma Investigational Site 6388 1

Harrow

  • Galderma Investigational Site 6394 1

Kingston upon Thames

  • Galderma Investigational Site 6393 1

Kirkcaldy

  • Galderma Investigational Site 6666 1

Metropolitan Borough of Wirral

  • Galderma Investigational Site 6402 1

Redhill

  • Galderma Investigational Site 5431 1

Sandbach

  • Galderma Investigational Site 6403 1

Swansea

  • Galderma Investigational Site 5989 1

Wolverhampton

  • Galderma Investigational Site 5944 1

Edinburgh

  • Lauriston Building 1
🇦🇺Australia41

Melbourne

  • Momentum Sunshine 1
  • Doherty Clinical Trials 1
  • Paratus Clinical Research Melbourne 1
  • Alfred Health 1

Liverpool

  • Aperio Clinical Research 1
  • Inmagene Site 28 1

Coorparoo

  • Cornerstone Centre for Clinical Research 2

Benowa

  • Inmagene Site 26 1
  • The Skin Center 1

Carlton

  • Inmagene Site 27 1
  • Skin Health Institute 1

Kogarah

  • Premier Specialists 1
  • St George Dermatology 1

Waitara

  • Innovate Clinical Research 2

Woolloongabba

  • Veracity Clinical Research 2

Adelaide

  • CMAX Clinical Research Pty Ltd 2

Botany

  • Emeritus Sydney 1

Camberwell

  • Emeritus Melbourne 1

Woden

  • Inmagene Site 25 1

Mitcham

  • Inmagene Site 24 1

Brookvale

  • Canopy Clinical Northern Beaches 1

Darlinghurst

  • Momentum Clinical Research 1

Kotara

  • Novatrials 1

Wollongong

  • Canopy Clinical Wollongong 1

Wellers Hill

  • Momentum Clinical Research 1

North Altona

  • Canopy Clinical Altona North 1

Nedlands

  • Captain Stirling Medical Centre 1

Charlestown

  • Novatrials 1

Birtinya

  • University of the Sunshine Coast Clinical Trials, Birtinya 1

Deakin

  • Paratus Clinical Research - Canberra Trial Clinic 1

Albion

  • Paratus Clinical Brisbane Pty Ltd 1

Blacktown

  • Paratus Clinical Research Western Sydney 1

Kanwal

  • Paratus Clinical Research Central Coast 1

Saint Albans

  • MCR Sunshine 1

Fremantle

  • Fremantle Dermatology 1

Perth

  • Linear Clinical Research 1

Bayswater

  • Veritus Research 1
🇮🇹Italy39

Roma

  • Leo Pharma Investigational site 1
  • AOU Sant'Andrea 1
  • Fondazione PTV - Policlinico Tor Vergata 1
  • Fondazione Policlinico Universitario A. Gemelli IRCCS 1
  • Istituto San Gallicano IRCCS - Istituti Fisioterapici Ospitalieri-Site Number: 3800002 1
  • Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia 1
  • Investigational Site Number: 005 1
  • Investigational Site Number: 009 1

Ancona

  • Leo Pharma Investigational site 1
  • Novartis Investigative Site 1
  • Azienda Ospedaliero Universitaria delle Marche-Site Number: 3800009 1

Brescia

  • Leo Pharma Investigational site 1
  • Investigational Site Number: 006 1
  • ASST Spedali Civili di Brescia 1

Rome

  • Leo Pharma Investigational site 1
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1
  • fondazione policlinico universitario agostino gemelli IRCCS 1

Naples

  • Universita degli Studi della Campania "Luigi Vanvitelli" - Azienda Ospedaliera Universitaria 1
  • Investigational Site Number: 010 1
  • Investigational Site Number: 011 1

Florence

  • Ospedale Piero Palagi 1
  • Investigational Site Number: 004 1

Pisa

  • Azienda Ospedaliero Universitaria Pisana (AOUP) 1
  • Novartis Investigative Site 1

Milan

  • Studio Medico Pigatto Bersani 1
  • Investigational Site Number: 001 1

Verona

  • Poliambulatorio Verona 1
  • Investigational Site Number: 014 1

Bologna

  • Università di Bologna 1
  • Investigational Site Number: 002 1

Padova

  • Leo Pharma Investigational site 1

Arezzo

  • Ospedale San Donato di Arezzo 1

Ferrara

  • Azienda Ospedaliera Universitaria di Ferrara Arcispedale Sant' Anna 1

Parma

  • Azienda Ospedaliero-Universitaria di Parma 1

Cona

  • Novartis Investigative Site 1

Voghera

  • Studio Medico 1

Novara

  • Ospedale Maggiore di Novara-Site Number: 3800005 1

Reggio Emilia

  • Arcispedale Santa Maria Nuova Azienda Ospedaliera di Reggio Emilia-Site Number : 3800006 1

Rozzano

  • IRCCS Istituto Clinico Humanitas - Dermatology Unit 1
🇳🇱Netherlands29

Utrecht

  • University Medical Center Utrecht 2
  • Leo Pharma Investigational site 1
  • Novartis Investigative Site 1
  • Diakonessenhuis 1
  • St Antonius ziekenhuis 1

Rotterdam

  • Novartis Investigative Site 1
  • Erasmus Medical Center 1

Nijmegen

  • Radboud University Medical Center 2

Maastricht

  • Maastricht University Medical Center+ 1
  • Maastricht Univeristy Medical Center 1

Amsterdam

  • Amsterdam University Medical Center 1
  • Department of Dermatology, Amsterdam University Medical Centres, University of Amsterdam, Research Institute Amsterdam Public Health and Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands 1

Groningen

  • University Medical Center Groningen 2

Leiden

  • Leiden University Medical Center 1
  • Centre for Human Drug Research 1

Zwolle

  • Isala Dermatologisch Centrum 1

Leeuwarden

  • Medisch Centrum Leeuwarden 1

Capelle aan den IJssel

  • IJsselland Ziekenhuis 1

Amersfoort

  • Meander Medisch Centrum 1

Delft

  • Reinier de Graaf ziekenhuis 1

Eindhoven

  • Catharina ziekenhuis 1

Haarlem

  • Spaarne Gasthuis 1

The Hague

  • Haga ziekenhuis 1

Almelo

  • Ziekenhuisgroep Twente 1

Enschede

  • Medisch Spectrum Twente 1

Hengelo

  • Ziekenhuisgroep Twente 1
🇨🇿Czechia28

Prague

  • Praglandia s.r.o. 2
  • Clintrial s.r.o. 2
  • MU Dr. Petr Arenberger, DrSc. MBA 1
  • Synexus Czech s.r.o. 1
  • Dermatology clinic MUDr. Blanka Havlickova 1
  • Fakultni Nemocnice Kralovske Vinohrady 1
  • Pratia Prague 1
  • Pratia Czech s.r.o. 1
  • Novartis Investigative Site 1
  • Investigational Site 1

Ostrava

  • CCR Ostrava s.r.o, 1
  • CCR Ostrava s.r.o. 1
  • CCR Ostrava, s.r.o. 1

Pardubice

  • CCR Czech Pardubice a.s. 1
  • Pratia Pardubice a.s. 1
  • Pratia Czech s.r.o. 1

Olomouc

  • AGE Centrum s.r.o. 1

Náchod

  • DERMAMEDICA s.r.o. 1

Plzen Bory

  • Novartis Investigative Site 1
🇳🇿New Zealand27

Auckland

  • Aotearoa Clinical Trials 2
  • Optimal Clinical Trials (North) 1
  • Inmagene Site 30 1
  • Pacific Clinical Research Network-West Auckland 1

Hamilton

  • Clinical Trials New Zealand 1
  • Inmagene Site 29 1
  • Momentum Hamilton 1
  • Clinical Trials New Zealand Ltd 1

Christchurch

  • Momentum Christchurch 1
  • MCR Christchurch 1
  • Optimal Clinical Trials Ltd - Christchurch 1

Upper Hutt

  • Momentum Hutt Valley 1
  • Pacific Clinical Research Network-Wellington 1
  • Pacific Clinical Research Network (PCRN) Wellington 1

Takapuna

  • Momentum Auckland 1
  • Pacific Clinical Research Network (PCRN) - Auckland 1

Palmerston North

  • Momentum Palmerston North 1
  • MCR Palmerston North 1

Waikanae

  • Momentum Kapiti 1
  • Momentum Clinical Research Kapiti 1

Pukekohe

  • Momentum Clinical Research Pukekohe 1

Dunedin

  • Momentum Clinical Research Dunedin 1

Nelson

  • Pacific Clinical Research Network-Tasman 1

Newtown

  • Medical Research Institute of New Zealand 1

Grafton

  • Optimal Clinical Trials Central Auckland 1

Otahuhu

  • Aotearoa Clinical Trials 1
🇭🇺Hungary24

Szeged

  • University of Szeged 2
  • Szegedi Tudományegyetem Bőrgyógyászati és Allergológiai Klinika 1
  • Komplex Labor Kft 1
  • Novartis Investigative Site 1
  • Investigational Site 1
  • University of Szeged, Albert Szent-Györgyi Clinical Centre, Department of Dermatology and Allergology 1

Pécs

  • Pécsi Tudományegyetem Klinikai Központ 2
  • University of Pecs 1
  • Pecsi Tudomanyegyetem 1
  • Novartis Investigative Site 1

Budapest

  • Clinexpert Kft. 2
  • Dept. Dermatology, Venereology and Dermatooncology, Semmelweis University 1
  • Novartis Investigative Site 1
  • Investigational Site 1

Békéscsaba

  • Trial Pharma Kft. 3

Debrecen

  • Debreceni Egyetem - Orvos es Egeszsegtudomanyi Centrum (DEOEC) (University of Debrecen Medical and Health Science Center) 1
  • Novartis Investigative Site 1
  • Investigational Site 1
🇹🇼Taiwan20

Taipei

  • Taipei Medical University Hospital 1
  • Novartis Investigative Site 1
  • National Taiwan University Hospital 1
  • Taipei Mackay Memorial Hospital 1
  • Taipei Veterans General Hospital 1
  • Tri-Service General Hospital 1

New Taipei City

  • Taipei Medical University-Shuang Ho Hospital 2
  • En Chu Kong hospital 1
  • Linkou Chang Gung Memorial Hospital 1
  • Taipei Medical University Shuang Ho Hospital 1

Kaohsiung City

  • Novartis Investigative Site 1
  • Kaohsiung Chang Gung Memorial Hospital 1
  • Kaohsiung Veterans General Hospital 1

Taichung

  • China Medical University Hospital 2

Taoyuan

  • Chang Gung Memorial Hospital-Linkou 1

Tainan

  • National Cheng Kung University Hospital 1
🇰🇷South Korea14

Seoul

  • Leo Pharma Investigational site 1
  • Novartis Investigative Site 1
  • Pfizer Tower 1

Ansan

  • Korea university Ansan hospital 1
  • Novartis Investigative Site 1

Ansan-si

  • Leo Pharma Investigational site 1

Gwangju

  • Leo Pharma Investigational site 1

Ilsan

  • Dongguk University Medical Center 1
🇨🇭Switzerland12

Zurich

  • University of Zurich 1
  • Institut für Dermatologie und Venerologie Stadtspital Zürich Europaallee 1
  • Allergy Unit, Dept. of Dermatology, Unviersity Hosptial of Zurich 1

Geneva

  • University Hospitals of Geneva 1

Basel

  • Universitätsspital Basel, Allergologie 1

Bern

  • Inselspital, Department of Dermatology 1

Buochs

  • Dermatology & Skin Care Clinic 1

Fribourg

  • HFR Hôpital Cantonal de Fribourg 1

Lausanne

  • Dermatologie CHUV 1

Lucerne

  • Luzerner Kantonsspital, Zentrum für Dermatologie und Allergologie 1

Sankt Gallen

  • Kantonsspital St. Gallen - Klinik für Dermatologie, Venerologie und Allergologie 1

Uster

  • PLAZA Kliniken 1
🇧🇪Belgium10

Brussels

  • Leo Pharma Investigational site 1
  • Universitair Ziekenhuis Brussel - Kinderziekenhuis 1

Leuven

  • Leo Pharma Investigational site 1
  • Center for Clinical Pharmacology University Hospitals Leuven (UZ Leuven) 1

Jette

  • Universitair Ziekenhuis Brussel 1
  • Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel (VUB) 1

Ghent

  • Leo Pharma Investigational site 1

Liège

  • Leo Pharma Investigational site 1

Bruges

  • AZ Sint-Jan Brugge-Oostende AV - Campus Sint-Jan 1

Namur

  • Clinique Ste Elisabeth 1
🇲🇽Mexico9

Mexico City

  • Hospital Infantil de Mexico Federico Gomez 1
  • Hospital Infantil de México Federico Gómez 1

Monterrey

  • Eukarya Pharmasite S.C. 2

Veracruz

  • Arké SMO S.A de C.V 1
  • Arke SMO S.A. de C.V. 1

Chihuahua City

  • Servicios Hospitalarios de Mexico S.A. DE C.V. 1
  • Servicios Hospitalarios de México S.A. de C.V. (Hospital Angeles Chihuahua) 1

Aguascalientes

  • Universidad Autónoma de Aguascalientes 1
🇧🇬Bulgaria9

Sofia

  • ASMC - IPSMC - skin and venereal diseases 1
  • Diagnostic Consultative Centre (DCC) - Foкus 5 1
  • Diagnostic Consultative Center "Ascendent" 1
  • Sitryx Clinical Site 1

Burgas

  • Medical Center Medconsult Burgas EOOD 1

Kazanlak

  • Medical Center Kazanlak EOOD 1

Lovech

  • Medical Center Medconsult Pleven-Lovech Branch 1

Pleven

  • Medical Center Medconsult Pleven OOD 1

Varna

  • Medical Centre Pratia Clinic EOOD 1
🇩🇰Denmark8

Gentofte Municipality

  • Copenhagen University Hospital of Copenhagen 2

Gistrup

  • Aalborg University 1
  • CNAP 1

Herlev

  • Sitryx Clinical Site 1

Aalborg

  • Aalborg University 1

Copenhagen

  • Dermatology Department Bispebjerg 1

Aarhus

  • Aarhus University Hospital 1
🇦🇪United Arab Emirates8

Abu Dhabi

  • Investigational Site: NMC Specialty Hospital LTD 1
  • NMC Specialty Hospital-Site Number : 7840002 1
  • Mediclinic Hospital, AUH-Site Number: 7840004 1

Fujairah

  • Investigational Site: Dibba Hospital 1

Ras al-Khaimah

  • Investigational Site: Ibrahem Bin Hamad Hospital 1

Sharjah city

  • Investigational Site: Al Qassimi Hospital 1

Al Karama

  • Dr Joseph Polyclinic Amber Clinic-Site Number: 7840005 1

Dubai

  • Dermatology and Aesthetic Center Rashid Hospital-Site Number : 7840003 1
🇸🇰Slovakia5

Bardejov

  • Novartis Investigative Site 1

Komárno

  • Novartis Investigative Site 1

Košice

  • Novartis Investigative Site 1

Prešov

  • Novartis Investigative Site 1
🇸🇪Sweden5

Stockholm

  • Karolinska Institutet 1
  • Atrium Health Care Centre 1
  • Neko Health Centre Regeringsgatan 1
  • Neko Health Centre Sibyllegatan 1

Linköping

  • Crown Princess Victoria Children´s Hospital 1
🇸🇦Saudi Arabia5

Jeddah

  • Investigational Site: Saudi Medical Services (Medical Fakeeh) 1
  • Investigational Site: King Faisal Specialist Hospital 1
  • Erfan and Bagedo Hospital-Site Number : 6820002 1
  • Medical Fakeeh-Site Number : 6820003 1

Riyadh

  • King Fahad Medical City-Site Number : 6820001 1
🇦🇷Argentina4

Caba

  • Novartis Investigative Site 1

Rosario

  • Novartis Investigative Site 1

Ciudad Autónoma de Buenos Aire

  • Cirec Latam 1
🇫🇮Finland4

Helsinki

  • Natural Resources Institute Finland 2

Tampere

  • Tampere University 2
🇵🇰Pakistan3

Peshawar

  • Hayatabad Medical Complex 1

Lahore

  • Shalamar Hospital Lahore 1

Rawalpindi

  • Fauji Foundation Hospital, Rawalpindi 1
🇭🇷Croatia3

Rijeka

  • Leo Pharma Investigational site 1

Zagreb

  • Leo Pharma Investigational site 1
🇮🇪Ireland3

Cork

  • Leo Pharma Investigational site 1

Crumlin

  • Leo Pharma Investigational site 1

Dublin

  • Sitryx Clinical Site 1
🇸🇬Singapore3

Singapore

  • National University Hospital 1
  • National University of Singapore 1
  • KK Women's & Children's Hospital 1
🇪🇬Egypt2

Cairo

  • Cairo University 1

Al Mansurah

  • Mansoura University Hospital 1
🇷🇴Romania2

Brasov

  • Leo Pharma Investigational site 1

Iași

  • Leo Pharma Investigational site 1
🇺🇦Ukraine2

Ivano-Frankivsk

  • Triveni Bio Site #12 1

Kyiv

  • Triveni Bio Site #10 1
🇨🇱Chile2

Las Condes

  • Clínica San Carlos de Apoquindo 1

Santiago

  • Hospital Clínico Universidad Católica 1
🇹🇷Turkey (Türkiye)2

Istanbul

  • Bezmialem Vakif University 1
  • Test Study Site - Replace 1
🇲🇱Mali2

Bamako

  • Dermatology Hospital of Bamako 1
  • Pneumology Ward, Point G University Hospital 1
🇭🇰Hong Kong1

Hong Kong

  • The Chinese University of Hong Kong 1
🇯🇴Jordan1

Amman

  • Triumpharma Clinical Research Unit at AlEssra Hospital 1
🇷🇺Russia1

Saint Petersburg

  • St. Petersburg State Budgetary Healthcare Institution "City Polyclinic No. 43" 1
🇲🇺Mauritius1

Quatre Bornes

  • Insight Research Ltd 1
🇵🇭Philippines1

Makati City

  • VMV Skin Research Center & Clinics 1
🇮🇳India1

New Delhi

  • CIDP 1
🇧🇷Brazil1

Osasco

  • Grupo Medcin 1
🇨🇮Côte d’Ivoire1

Taabo

  • Taabo Health and Demographic Surveillance 1
🇶🇦Qatar1

Doha

  • Investigational Site: Hamad Medical Corporation 1
🇲🇾Malaysia1

Kajang

  • Private hospital 1
🇨🇷Costa Rica1

San José

  • Caja Costarricense del Seguro Social 1

Source: ClinicalTrials.gov study locations, fetched 2026-11-10. Counts are trials at that site.